ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,rank,leading_edge,core_enrichment,gs_description,results_path
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,58,0.797287094717143,2.97736608258268,1e-10,1.31416666666667e-08,1.05877192982456e-08,256,tags=71%, list=11%, signal=64%,RPS25/RPS4X/EEF1A1/RPS3/RPS27A/RPL32/RPL30/EEF1B2/RPL5/RPS6/RPL14/TPT1/RPL13/RPS5/RPS14/EEF1G/RPL10/NOP53/RPS3A/RPL21/RPL4/RPS23/RPL24/RPS8/RPL18/RPL18A/RPS16/RPL29/RPL6/EIF4B/RPL28/RPS10/RPS13/RPS7/EEF2/RPL36A/RPL7A/RPS19/RACK1/RPL26/RPL13A,Genes translationally regulated in MEF cells (embryonic fibroblasts) in response to serum starvation and by rapamycin (sirolimus) [PubChem=6610346].,C2/CGP
CHEN_METABOLIC_SYNDROM_NETWORK,CHEN_METABOLIC_SYNDROM_NETWORK,265,-0.645378124443171,-2.26754465594659,1e-10,1.31416666666667e-08,1.05877192982456e-08,358,tags=46%, list=16%, signal=44%,ARAP1/ARPC5/IFNGR1/DAPP1/TUBA1A/SERPINB6/MAN2B1/BACH1/PLAC8/SCPEP1/SH3BP2/CSTB/CTSD/NCF4/ARRB2/THEMIS2/RGS19/TPM3/LYL1/UNC93B1/PLCG2/PIK3AP1/LCP1/CD300A/EMP3/CFL1/PPIB/GLRX/FKBP1A/DYNLL1/PRKCD/ATP6V1B2/TAGLN2/VSIR/CTSB/STX7/PTPN18/OAS1/ABI3/RNH1/VAMP8/MTPN/C19orf38/NAGK/SCIMP/FLNA/LMO2/LAT2/CASP1/SLC11A1/CD63/ARPC2/SYNGR2/CLEC7A/VIM/HVCN1/PTPRE/ASAH1/GLIPR1/RHOC/LRRC25/HLA-DMB/TNFSF13B/CD36/LY86/MYO1F/CD37/PLEKHO1/ATP6V0B/PTPN6/RAB31/CTSH/PILRA/BLVRB/MPEG1/ARPC1B/SYK/CAPG/CSF3R/ANXA5/NCF2/CFP/IGSF6/MS4A7/NPC2/ITGB2/ANXA2/STXBP2/FOS/SRGN/PLEK/CD68/SH3BGRL3/LGALS3/CLIC1/PYCARD/LYN/TNFAIP2/CD14/MS4A6A/CYBB/GRN/CYBA/COTL1/S100A11/IFI30/SAT1/VCAN/SPI1/LGALS1/HLA-DQA1/S100A6/AIF1/SERPINA1/CTSS/PSAP/FCER1G/TYROBP/CD74/LYZ/S100A8,Genes forming the macrophage-enriched metabolic network (MEMN) claimed to have a causal relationship with the metabolic syndrom traits.,C2/CGP
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,44,0.790746766631746,2.8111091578679,1e-10,1.31416666666667e-08,1.05877192982456e-08,303,tags=70%, list=13%, signal=62%,RPS3/RPL32/EEF1B2/RPSA/RPS6/NPM1/RPL14/RPS14/EEF1G/RPL36/RPL35A/RPL21/RPL4/RPS23/RPL37/RPL24/RPL18/RPS16/RPL29/RPL28/RPS15/RPS13/EEF2/RPLP2/RPL7A/RPS19/HNRNPA1/RPL13A/RPLP1/RPS9/EIF4A2,Protein biosynthesis, transport or catabolism genes up-regulated in hyperploid multiple myeloma (MM) compared to the non-hyperploid MM samples.,C2/CGP
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,43,-0.856856920245403,-2.44642099963457,1e-10,1.31416666666667e-08,1.05877192982456e-08,227,tags=77%, list=10%, signal=70%,LILRB3/CCL5/AOAH/CASP1/SLC11A1/LILRB1/TPI1/FPR1/PILRA/CX3CR1/NCF1/CAPG/NCF2/IGSF6/LGALS3/LGALS2/FGL2/CSTA/CD14/MS4A6A/FGR/TYMP/IFI30/S100A12/MNDA/VCAN/CEBPD/LGALS1/SERPINA1/FCN1/S100A9/LYZ/S100A8,Genes down-regulated in leukemic stem cells (LSC), defined as CD34+CD38- [GeneID=947;952] cells from AML (acute myeloid leukemia patients) compared to the CD34+CD38+ cells.,C2/CGP
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,96,-0.745523901943812,-2.39515660979368,1e-10,1.31416666666667e-08,1.05877192982456e-08,355,tags=52%, list=15%, signal=46%,DBI/SH3BGRL/SERPINB6/TPM4/SCPEP1/CTSD/NCF4/SKAP2/ANXA1/REEP5/MIS18BP1/TXN/LYL1/GSTO1/PLCG2/EMP3/GLRX/SNX3/RNH1/CCL5/DUSP1/LAT2/CASP1/SNX10/YBX3/TPI1/PLBD1/MYO1F/AHNAK/CAPG/GAPDH/ANXA2/CD68/LGALS3/S100A10/LYN/FGL2/EFHD2/S100A11/IFI30/S100A4/MS4A1/IFITM3/LGALS1/HLA-DQA1/S100A6/HLA-DRB1/TYROBP/CD74/CST3,Genes up-regulated at the peak of an antigen response of naive CD8+ [GeneID=925;926] T-cells.,C2/CGP
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,60,-0.78580247690651,-2.39745564691451,1e-10,1.31416666666667e-08,1.05877192982456e-08,213,tags=53%, list=9%, signal=50%,CCL5/IQGAP1/CASP1/SNX10/HLA-DMB/FPR1/MPEG1/CFP/HCK/ITGB2/CD68/HLA-DMA/LGALS3/CLIC1/FGL2/CD14/CYBB/GRN/CYBA/S100A11/S100A4/MNDA/HLA-DQA1/S100A6/AIF1/CTSS/HLA-DRB1/TYROBP/S100A9/CD74/LYZ/S100A8,Hepatic graft versus host disease (GVHD), day 35: genes up-regulated in allogeneic vs syngeneic bone marrow transplant.,C2/CGP
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,101,0.708173604920627,2.87095437101104,1e-10,1.31416666666667e-08,1.05877192982456e-08,492,tags=66%, list=21%, signal=55%,CCR7/SARAF/EEF1A1/RPS27A/RPL30/EEF1B2/RPL5/DGKA/RPS6/NPM1/RPL14/RPL13/TRAF3IP3/EEF1G/BTG1/RPL10A/RPL21/RPL11/RPL19/RPL4/RBL2/RPS28/RPL37/RPL24/SATB1/HSPA8/RPL22/RPL17/TOMM7/RPLP0/RPL23A/RPL6/EIF4B/GPR183/RPS7/EEF2/PDE3B/FYN/FAM102A/EIF3E/ATM/RPL13A/IPCEF1/RPL41/RPLP1/NACA/EIF4A2/ITPKB/ATP6V0E2/SRSF5/DYRK2/ANP32B/EIF3H/RPS20/SRSF8/RPL7/BTF3/EIF3F/TMC6/CIRBP/HNRNPDL/OGT/GLS/CCSER2/TUT4/FBL/ERCC5,Genes down-regulated in peripheral blood mononuclear cells (PBMC) from sickle cell disease patients compared to those from healthy subjects.,C2/CGP
LEE_DIFFERENTIATING_T_LYMPHOCYTE,LEE_DIFFERENTIATING_T_LYMPHOCYTE,120,0.593917034081729,2.49177262722988,1e-10,1.31416666666667e-08,1.05877192982456e-08,310,tags=43%, list=14%, signal=40%,IL7R/TCF7/LEF1/CD3D/LTB/CD3G/LCK/TRAT1/AQP3/MAL/EVL/RGCC/DGKA/ITK/TRAF3IP3/SELL/CD2/FYB1/BTG1/ITM2A/TAGAP/MGAT4A/LAT/SATB1/TMC8/RHOH/SLFN5/ARHGAP15/PDE7A/CD96/EPB41/TRBC2/PRKCH/SEMA4D/BCL11B/TBC1D10C/CD247/RASGRP1/IKZF1/GATA3/TRBC1/MZT2B/TNFAIP8/FKBP5/PTPRC/IPCEF1/ARHGAP45/PAG1/FAM107B/GIMAP2/CYFIP2/CYTH1,Genes enriched at every T lymphocyte differentiation stage compared to the early passage fetal thymic stromal cultures (TSC).,C2/CGP
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,95,-0.758288347796832,-2.43635277233536,1e-10,1.31416666666667e-08,1.05877192982456e-08,165,tags=52%, list=7%, signal=50%,CLEC7A/TNFRSF1B/PECAM1/ALOX5/HLA-DMB/CD37/FPR1/TIMP1/RAB31/LSP1/CTSH/ARPC1B/CAPG/NCF2/HCK/ITGB2/SRGN/PLEK/CPVL/HLA-DMA/LYN/FGL2/CD14/MS4A6A/CYBB/CFD/TYMP/CYBA/IFI30/SAT1/HLA-DQB1/MNDA/CD79A/MS4A1/CEBPD/HLA-DQA1/SERPINA1/CTSS/HLA-DPB1/FCER1G/HLA-DPA1/FCN1/HLA-DRB1/TYROBP/HLA-DRA/S100A9/CD74/LYZ/S100A8,Genes up-regulated in pulpal tissue extracted from carious teeth.,C2/CGP
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,163,0.639485384185826,2.78254445355276,1e-10,1.31416666666667e-08,1.05877192982456e-08,420,tags=56%, list=18%, signal=50%,NOSIP/C12orf57/RPL3/CD27/RPS25/RPS27/RPS4X/MAL/RPS3/LEPROTL1/RPL32/RPS18/EEF1B2/RPSA/DGKA/RPS6/RPL14/RPL13/RPS5/RPL34/TRAF3IP3/EEF1G/RPL10/RPL36/NOP53/RPS21/GAS5/RPL35A/RPS3A/RPL10A/SKAP1/TAGAP/RPL19/RPL4/RPL37/RPL24/SATB1/PRMT2/LBH/TMC8/RHOH/RPL22/LINC01138/RPL18A/OCIAD2/RPS16/RPLP0/RPL29/PDE7A/RPL23A/EPB41/RPL28/RPS10/RPS15/RPS13/MAML2/RPS7/CYTIP/FCMR/RPLP2/RPL36A/FAM102A/RPL38/RPL7A/IKZF1/RPL13A/ST13/RPL12/EIF2S3/ATP8B2/PHF1/TMEM63A/ARHGAP45/EIF4A2/ITPKB/PITPNC1/MYL12A/EPC1/HIVEP2/ISG20/ST3GAL1/SLC7A6/NSD3/RPS20/SRSF8/ITGB2-AS1/SFI1/RPL35/PPP2R5C/FAU/TGFBR2/PDCD4,Genes down-regulated in blood samples from bladder cancer patients.,C2/CGP
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,71,-0.761216608523288,-2.37008088930541,1e-10,1.31416666666667e-08,1.05877192982456e-08,305,tags=61%, list=13%, signal=54%,SKAP2/ANXA1/QKI/EVI2B/PLCG2/EMP3/GLRX/MSN/RNASE6/CCL5/TGFBI/LMO2/CASP1/SLC7A7/CLEC7A/PECAM1/GLIPR1/ALOX5/HLA-DMB/MEF2C/SRGN/CPVL/HLA-DMA/ZEB2/LYN/FGL2/MS4A6A/IFI30/HLA-DQB1/S100A4/MNDA/VCAN/LGALS1/HLA-DQA1/CTSS/FTL/HLA-DPB1/FCER1G/HLA-DPA1/HLA-DRB1/TYROBP/HLA-DRA/CD74,Genes up-regulated in invasive ductal carcinoma (IDC) relative to ductal carcinoma in situ (DCIS, non-invasive).,C2/CGP
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,153,0.546738850950451,2.35822804324194,1e-10,1.31416666666667e-08,1.05877192982456e-08,454,tags=48%, list=20%, signal=42%,IL7R/LEF1/CCR7/ETS1/CAMK4/GIMAP7/TRAT1/INPP4B/LEPROTL1/TRAF3IP3/SELL/ABLIM1/KLF2/TESPA1/FYB1/IL6ST/CD28/RBL2/GIMAP4/RPL37/SATB1/RHOH/S1PR1/ZAP70/GIMAP1/ARHGAP15/PDE7A/CD96/EPB41/ADD3/NCK2/ITGA6/RASA3/PRKCH/BCL11B/GPR183/SCML4/CLEC2D/PLCG1/CYTIP/FYN/THEMIS/MT-ND4L/GATA3/MBNL1/BCL2/PTPRC/ZC3HAV1/MLLT3/FOXP1/CDKN1B/PAG1/FAM107B/CDC42SE2/CYTH1/SYNE2/DOCK10/ZBTB25/HIVEP2/GPRIN3/STAT5B/NSD3/RGS10/CD69/PPP2R5C/MDFIC/GIMAP6/ARHGEF3/TGFBR2/STAT4/ESYT2/SPTBN1/CHURC1/UBAC2,Genes whose promoters are bound by FOXP3 [GeneID=50943] based an a ChIP-chip analysis.,C2/CGP
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,96,-0.688205570864852,-2.21100908724187,1.35224421336506e-10,1.64037624959746e-08,1.32158604496488e-08,381,tags=55%, list=17%, signal=48%,MYO1G/GLIPR2/DOK2/SERPINB6/SEC61B/SH3BP2/CSTB/NCF4/TNFSF10/COMT/PLCG2/PPIB/GLRX/STX7/CCL5/SCIMP/CAPNS1/JUNB/LAT2/CASP1/CD63/JAML/VIM/HVCN1/IFITM2/DUSP6/ASAH1/GLIPR1/ALDOA/MYO1F/CALHM6/MYL6/CX3CR1/AHNAK/CAPG/CTSW/NRGN/ANXA2/SH3BGRL3/LGALS3/TSPO/S100A10/COTL1/S100A11/IFI30/S100A4/NKG7/IFITM3/LGALS1/S100A6/FTL/FCER1G/TYROBP,Genes up-regulated in ITNK cells (T-lymphocyte progenitors (DN3 cells) reprogrammed to natural killer (NK) cells by ablation of BCL11B [GeneID=64919] gene), compared to the parental DN3 cells.,C2/CGP
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,43,-0.814556202067737,-2.32564778440532,1.59705314812384e-10,1.70607281830973e-08,1.37451516316781e-08,332,tags=79%, list=14%, signal=69%,SCPEP1/CTSD/TNFSF10/TCIRG1/PRKCD/LILRB3/CAST/CASP1/SNX10/LILRB1/MARCKS/CD36/TBXAS1/FPR1/PILRA/CX3CR1/TMEM176B/NCF1/LILRB2/HCK/PLEK/CPVL/LGALS2/FGL2/TNFAIP2/CD14/FGR/TYMP/IFI30/SAT1/VCAN/S100A6/SERPINA1/FCN1,Genes up-regulated in acute myeloid leukemia (AML) patients with mutated NPM1 [GeneID=4869].,C2/CGP
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,86,-0.706216004183436,-2.26010334378702,1.62277059446075e-10,1.70607281830973e-08,1.37451516316781e-08,349,tags=58%, list=15%, signal=51%,LRRFIP1/MAN2B1/SCPEP1/NCF4/THEMIS2/ANXA1/LCP1/RAB11FIP1/EMP3/TCIRG1/CTSC/SWAP70/RHOG/CTSB/LILRB3/TGFBI/IQGAP1/CAST/CASP1/SLC11A1/SYNGR2/TNFRSF1B/CEBPB/PLBD1/ALOX5/RAB32/MYO1F/PTPN6/TIMP1/BLVRB/ARPC1B/NCF2/LILRB2/NPC2/ITGB2/ANXA2/STXBP2/LGALS3/CLIC1/CSTA/CD14/CTSZ/TYMP/GRN/S100A11/IFI30/SAT1/S100A4/LGALS1/SERPINA1,Genes correlated with mesenchymal type of glioblastoma multiforme tumors.,C2/CGP
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,77,-0.714443703077142,-2.24672315380536,4.00924968588592e-10,3.95161672165131e-08,3.18366077030546e-08,314,tags=51%, list=14%, signal=45%,CTSD/ANXA1/BID/EMP3/ACTN4/RNASE6/CTSC/ATP6V1B2/CTSB/VAMP8/SYNGR2/PTPRE/DUSP6/ALOX5/TIMP1/CTSH/CX3CR1/CAPG/GPX1/APLP2/NCF2/IGSF6/NPC2/ANXA2/LGALS3/TSPO/S100A10/LYN/MS4A6A/CYBA/S100A11/IFI30/S100A4/MNDA/VCAN/LGALS1/LST1/SERPINA1/CTSS,Genes up-regulated in papillary thyroid carcinoma (PTC) compared to normal tissue.,C2/CGP
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,23,-0.887900530570947,-2.24139167345674,1.04101671808509e-09,9.65696096717758e-08,7.78023020884647e-08,210,tags=78%, list=9%, signal=72%,TGFBI/DUSP1/SLC11A1/CLEC7A/FPR1/LSP1/MPEG1/HCK/FOS/PLEK/MS4A6A/FGR/CYBB/S100A4/VCAN/CTSS/PSAP/LYZ,Genes down-regulated in hematopoietic precursor cells conditionally expressing HOXA9 and MEIS1 [GeneID=3205;4211].,C2/CGP
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,126,-0.632470364896812,-2.09105330790715,1.5556037334595e-09,1.36288171536979e-07,1.09801971127814e-07,291,tags=30%, list=13%, signal=28%,SKAP2/TNFSF10/EVI2B/LCP1/ADA2/GDI2/CTSC/CTSB/VAMP8/CRTAP/CASP1/SLC11A1/ACTB/LILRB1/RHOA/NEAT1/MPEG1/CX3CR1/ITGB2/SRGN/HLA-DMA/LYN/CD14/MS4A6A/HLA-DQB1/MNDA/VCAN/LST1/AIF1/CTSS/FCER1G/HLA-DPA1/HLA-DRB1/TYROBP/HLA-DRA/S100A9/CD74/LYZ,Genes up-regulated in samples with systolic heart failure compared to normal hearts.,C2/CGP
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,96,-0.665501609647443,-2.13806770650733,2.43689787178162e-09,2.02262523357874e-07,1.62954888157363e-07,331,tags=45%, list=14%, signal=40%,NOTCH2/NCOA4/MYD88/CTSD/MT2A/CD300A/PRKCB/TCIRG1/NUP214/CTSB/AOAH/LMO2/CASP1/CD63/SNX10/SLC7A7/CNPY3/TIMP2/IFITM2/DUSP6/ASAH1/PECAM1/ALOX5/LTA4H/LY86/FPR1/CX3CR1/MEF2C/APLP2/ANXA5/LILRB2/LGALS3/CD14/CYBB/CFD/TYMP/S100A12/NKG7/FTH1/HLA-DQA1/AIF1/FCN1/S100A9,Genes up-regulated in peripheral blood mononucleocytes by HGF [GeneID=3082] compared to those regulated by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].,C2/CGP
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,106,-0.650427188446922,-2.11699038245553,4.91080536629115e-09,3.87217003132057e-07,3.11965372479654e-07,337,tags=44%, list=15%, signal=40%,PLAC8/NOTCH2/NCOA4/MYD88/CTSD/MT2A/MIS18BP1/CD300A/HERPUD1/PRKCB/TCIRG1/NUP214/CTSB/AOAH/LMO2/CASP1/SNX10/SLC7A7/CNPY3/TIMP2/IFITM2/DUSP6/ASAH1/PECAM1/ALOX5/LTA4H/LY86/FPR1/CX3CR1/MEF2C/APLP2/ANXA5/CFP/LILRB2/LGALS3/CD14/MS4A6A/CYBB/CFD/TYMP/S100A12/VCAN/NKG7/HLA-DQA1/AIF1/FCN1/S100A9,Genes down-regulated in peripheral blood monocytes by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].,C2/CGP
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,124,-0.619935856883516,-2.04918515591151,9.79023750338349e-09,7.35200216325512e-07,5.9232163742275e-07,421,tags=51%, list=18%, signal=44%,HEBP2/TPST2/MFSD1/TPP1/CAT/SERP1/ATOX1/ACTR2/CMTM6/LY6E/RAB5C/CLTA/ARPC5/CAP1/TPM4/SEC61B/SCPEP1/ZYX/CSTB/SKAP2/ANXA1/REEP5/TGFB1/ATG3/GSTO1/ACTN4/GLRX/MSN/TAGLN2/SWAP70/CTSB/STX7/SNX2/TGFBI/IQGAP1/DUSP1/CAST/ATP6V0D1/TIMP2/RHOA/GLIPR1/RHOC/AP2S1/RAB32/LRP1/TLN1/GNAI2/TIMP1/RAB31/RAC1/ARPC1B/CAPG/APLP2/ANXA5/ARPC3/ANXA2/TSPO/CLIC1/S100A10/GRN/VCAN/S100A6/CST3,Genes commonly down-regulated in human alveolar rhabdomyosarcoma (ARMS) and its mouse model overexpressing PAX3-FOXO1 [GeneID=5077;2308] fusion.,C2/CGP
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,174,-0.57002340781098,-1.95553399151614,1.10352628993228e-08,7.91027708737821e-07,6.37299632511131e-07,379,tags=40%, list=17%, signal=36%,PSMB10/PARP14/GLIPR2/PSMB9/LY6E/TUBA1A/MAN2B1/PFN1/PARVG/EHBP1L1/THEMIS2/RGS19/TPM3/CRIP1/EMP3/PSME2/RNASE6/TAGLN2/VSIR/C4orf48/CCL5/TGFBI/ODF3B/CASP1/PGLS/JAML/SYNGR2/CLEC7A/TIMP2/VIM/PTPRE/RHOA/ALOX5/TBXAS1/MYO1F/PLEKHO1/CALHM6/PTPN6/TIMP1/RAB31/MPEG1/CX3CR1/ARPC1B/NCF1/MS4A7/ITGB2/ANXA2/SRGN/HLA-DMA/CLIC1/ZEB2/LYN/TNFAIP2/TKT/CD14/MS4A6A/NAPSB/TYMP/GRN/HLA-DQB1/VCAN/NKG7/HLA-DQA1/LST1/FCER1G/HLA-DPA1/HLA-DRB1/TYROBP/HLA-DRA/LYZ,Genes whose expression increases with age in normal kidney.,C2/CGP
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,33,0.748099510847657,2.43221668790626,1.27442559859204e-08,8.73812682165061e-07,7.03996200229101e-07,443,tags=79%, list=19%, signal=64%,RPL5/RPS6/TPT1/RPS5/EEF1G/RPS28/RPL22/RPL17/RPS16/RPLP0/ITGA6/RPL6/EIF4B/EEF2/RPS19/RPL13A/RPS9/RPL37A/RPS20/CD69/RPL7/EIF3L/FAU/FXYD5/RPL27/TOMM20,Up-regulated genes significantly associated with positive minimal residual disease (MRD) on day 46 after chemotherapy treatment of children with acute lymphoblastic leukemia (ALL).,C2/CGP
BILANGES_SERUM_RESPONSE_TRANSLATION,BILANGES_SERUM_RESPONSE_TRANSLATION,22,0.821243384823304,2.45896770618084,1.95279860499282e-08,1.26674763287329e-06,1.02056829615062e-06,252,tags=82%, list=11%, signal=74%,RPS4X/EEF1A1/RPS3/EEF1B2/RPS6/RPL14/RPS5/EEF1G/RPL10/RPL21/RPL4/RPS8/RPL18A/RPL29/RPL6/RPS7/RPS19/RACK1,Genes translationally repressed upon serum deprivation in MEF cells (embryonic fibroblast).,C2/CGP
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,49,-0.752970419528486,-2.20482182813664,2.00816048331212e-08,1.26674763287329e-06,1.02056829615062e-06,257,tags=55%, list=11%, signal=50%,GRINA/GLRX/ATP6V1B2/VSIR/TGFBI/IQGAP1/AOAH/JUNB/PGD/FPR1/NEAT1/MPEG1/CAPG/ANXA5/HCK/ITGB2/CD68/CSTA/FGR/CYBB/GRN/S100A11/SAT1/CEBPD/S100A6/CTSS/TYROBP,Genes defining differentiation potential of the bipotential myeloid cell line FDB.,C2/CGP
ONKEN_UVEAL_MELANOMA_UP,ONKEN_UVEAL_MELANOMA_UP,203,-0.542730101861396,-1.88194042901701,2.7155513420764e-08,1.63829765527868e-06,1.31991140401253e-06,454,tags=33%, list=20%, signal=29%,SOD2/CYC1/PSMA7/VMP1/PKM/CDC42EP3/LAPTM5/TPST2/ADGRE5/IFI16/ENY2/WSB1/CALR/LAMTOR2/PSMB9/LY6E/LAP3/POMP/IFNGR1/LRRFIP1/SULT1A1/PFN1/MBD2/MT2A/MTDH/CUX1/COMT/EMP3/ACTN4/PSME2/GRINA/MSN/CTSC/FKBP1A/TAGLN2/CTSB/MTSS1/IQGAP1/CASP1/ARPC2/ACTB/TIMP2/IFITM2/LRP1/RAB31/CTSH/HLA-DMA/LGALS3/ZEB2/LYN/TNFAIP2/TYMP/COTL1/S100A11/CEBPD/IFITM3/LGALS1/S100A6/CTSS/HLA-DPB1/PSAP/FCER1G/HLA-DPA1/HLA-DRB1/TYROBP/HLA-DRA/CD74,Genes up-regulated in uveal melanoma: class 2 vs class 1 tumors.,C2/CGP
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,138,-0.596991433518191,-2.00708384358048,2.80494842691974e-08,1.63829765527868e-06,1.31991140401253e-06,526,tags=49%, list=23%, signal=40%,TRIM38/CTSA/DDT/P4HB/PSMB8/POLD4/SPG21/HCLS1/HEXB/UNC119/PKM/CDC42EP3/LAPTM5/RASSF2/MFSD1/TPP1/UQCRC1/CAT/ENO1/ACTR2/SCPEP1/EHBP1L1/PPT1/ATG3/BID/EVI2B/BLOC1S1/LCP1/GRB2/RNASE6/COX8A/PRKCD/IQGAP1/FLNA/LAT2/CASP1/ARPC2/SNX10/SYNGR2/CNPY3/PECAM1/MYO1F/SERF2/CD302/PILRA/NCF1/SYK/CAPG/AP1S2/LILRB2/HCK/ITGB2/NRGN/SRGN/OAZ1/PYCARD/CSTA/TNFAIP2/EFHD2/GRN/CYBA/S100A4/NKG7/SPI1/LGALS1/LST1/S100A6,The 'MLL signature 2': genes up-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to the AML cases with intact MLL and NPM1 [GeneID=4869].,C2/CGP
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,51,-0.750322927758161,-2.23363248356772,2.97124020587903e-08,1.67344493023972e-06,1.34822816860751e-06,267,tags=43%, list=12%, signal=39%,EMP3/PPIB/NUP214/SLC11A1/TNFRSF1B/DUSP6/LTA4H/CD37/NCF1/LGALS2/FGL2/CD14/CYBB/S100A12/S100A4/LST1/SERPINA1/FCER1G/FCN1/S100A9/LYZ/S100A8,Genes down-regulated during in vitro maturation of CD14+ [GeneID=929] monocytes (day 0) into immature (day 7) and mature dendritic cells (day 14).,C2/CGP
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,30,0.754894242228851,2.39256896084798,3.71710182991369e-08,2.02133433992203e-06,1.62850885978433e-06,256,tags=63%, list=11%, signal=57%,RPS12/RPS4X/RPS3/RPS27A/RPSA/RPL9/RPS3A/RPL17/RPLP0/RPL29/RPL23A/RPL6/RPL28/RPS10/RPS7/RPL7A/HNRNPA1/RPL31/RPL13A,Up-regulated genes distinguishing hepatocellular carcinoma (HCC) samples positive for EPCAM [GeneID=4072] from the negative ones.,C2/CGP
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,97,-0.632676837561505,-2.03224614221439,1.24275798699096e-07,6.53276448494916e-06,5.26318908876524e-06,251,tags=53%, list=11%, signal=49%,IRF1/PFN1/ATP6V1F/ARF5/ANXA1/LCP1/MSN/RNASE6/CTSC/ATP6V1B2/CCL5/IQGAP1/PAK1/LGALS9/FLNA/ARPC2/TIMP2/TNFRSF1B/RHOA/ASAH1/GLIPR1/AP2S1/ALDOA/CD37/GNAI2/ATP6V0B/RAB31/LSP1/ARPC1B/ANXA5/NPC2/ITGB2/SRGN/HLA-DMA/OAZ1/S100A10/LYN/FGL2/CYBB/GRN/CYBA/S100A11/IFI30/GSTP1/HLA-DQB1/VCAN/LGALS1/AIF1/CTSS/HLA-DPB1/CD74,Genes from 'subtype S1' signature of hepatocellular carcinoma (HCC): aberrant activation of the WNT signaling pathway.,C2/CGP
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,49,-0.73223267711053,-2.14409829111108,1.6025757146488e-07,8.15245774839082e-06,6.56811167260136e-06,181,tags=39%, list=8%, signal=36%,SLC11A1/SNX10/HLA-DMB/LY86/MPEG1/HCK/HLA-DMA/CLIC1/FGL2/CD14/CYBA/MNDA/HLA-DQA1/CTSS/HLA-DRB1/TYROBP/HLA-DRA/CD74/LYZ,Hepatic graft versus host disease (GVHD), day 7: up-regulated in allogeneic vs syngeneic bone marrow transplant.,C2/CGP
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,132,-0.583288583954857,-1.95134263957413,1.70069752869238e-07,8.38125000858713e-06,6.7524405168806e-06,316,tags=41%, list=14%, signal=37%,TPP1/MEGF9/CAT/RNASET2/PSMB9/PRDX5/LRRFIP1/NOTCH2/CSTB/CTSD/ANXA1/TNFSF10/UNC93B1/NBPF14/TCIRG1/CTSB/VAMP8/TGFBI/IQGAP1/FLNA/CRTAP/ACTB/SYNGR2/TIMP2/VIM/PTPRE/CEBPB/MARCKS/ASAH1/ATP6V0C/LRP1/NEAT1/TIMP1/ARPC1B/AHNAK/APLP2/NPC2/HLA-DMA/BRI3/TNFAIP2/TKT/GABARAP/EFHD2/GRN/S100A4/CEBPD/IFITM3/CTSS/HLA-DPB1/PSAP/HLA-DPA1/HLA-DRB1/HLA-DRA/CST3,Genes up-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.,C2/CGP
MARTENS_TRETINOIN_RESPONSE_DN,MARTENS_TRETINOIN_RESPONSE_DN,236,0.390664184792707,1.82614543574582,2.53572277617556e-07,1.19201902898527e-05,9.60362425648449e-06,256,tags=23%, list=11%, signal=23%,LDHB/RPS12/RPL3/RPS25/RPS27/RPS4X/EEF1A1/RPS3/RPS27A/RPL32/RPL30/EEF1B2/RPL5/RPSA/RPS6/RPL14/RPS5/RPL34/RPS14/RPL10/RPL36/RPL9/RPL10A/RPL21/RPL11/RPL19/RPL4/RPS23/RPL37/RPL24/RPS8/RPL18/HSPA8/RPL17/MYC/HINT1/RPL18A/RPS16/RPLP0/RPL29/RPL23A/HSPB1/RPS10/NAP1L4/PTPRCAP/RPL7A/PABPC1/RPS19/SLC2A4RG/HNRNPA1/RPL31/RACK1/RPL26/RPL13A,Genes down-regulated in NB4 cells (acute promyelocytic leukemia, APL) in response to tretinoin [PubChem=444795]; based on Chip-seq data.,C2/CGP
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,53,-0.707702890252359,-2.1283631277248,2.56998395596064e-07,1.19201902898527e-05,9.60362425648449e-06,287,tags=40%, list=13%, signal=35%,CRIP1/LYL1/LCP1/CALM2/TUBA1B/CRTAP/GNAI2/APLP2/ANXA2/CLIC1/S100A10/CTSZ/CFD/S100A11/SAT1/LGALS1/S100A6/CTSS/TYROBP/CD74/LYZ,Genes up-regulated in pancreatic cells from mice with double knockout of E2F1 [GeneID=1869] and E2F2 [GeneID=1870] compared to wild type.,C2/CGP
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,59,-0.701000144075157,-2.13806877496956,3.2028621464807e-07,1.44311817285716e-05,1.16266304084277e-05,418,tags=61%, list=18%, signal=51%,LAPTM5/IFI16/TPP1/RNASET2/PSMB10/PSMB9/LAP3/PLAC8/THEMIS2/PPT1/ADA2/CFL1/PSME2/CTSC/CTSB/CCL5/SLC7A7/HLA-DMB/RAB31/IGSF6/SRGN/HLA-DMA/LGALS3/S100A10/FGL2/COTL1/IFI30/HLA-DQB1/HLA-DPB1/FCER1G/HLA-DPA1/HLA-DRB1/TYROBP/HLA-DRA/CD74/LYZ,Genes induced in the liver during hepatitis B (HBV) viral clearance in chimpanzees.,C2/CGP
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,128,-0.582096630164772,-1.93084623482497,4.25017309107856e-07,1.86181193461969e-05,1.49998798857656e-05,481,tags=45%, list=21%, signal=37%,POLD4/SPG21/HCLS1/HEXB/UNC119/PKM/CDC42EP3/LAPTM5/RASSF2/MFSD1/TPP1/UQCRC1/CAT/ENO1/ACTR2/SCPEP1/EHBP1L1/ATG3/BID/EVI2B/LCP1/GRB2/RNASE6/DYNLL1/COX8A/PRKCD/NAGK/FLNA/LYST/LAT2/CASP1/ARPC2/SNX10/SYNGR2/CNPY3/IFNGR2/PECAM1/MYO1F/CD302/PILRA/ARPC1B/SYK/CAPG/LILRB2/ITGB2/OAZ1/PYCARD/CSTA/EFHD2/GRN/CYBA/S100A4/NKG7/SPI1/LGALS1/LST1/S100A6,The 'MLL signature 1': genes up-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to all AML cases with the intact gene.,C2/CGP
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,104,-0.608016352586808,-1.97677327864878,5.80427204616629e-07,2.47387486940655e-05,1.99310280504202e-05,289,tags=35%, list=13%, signal=32%,LAMTOR4/CD300A/GDI2/GLRX/CTSC/C1orf162/CTSB/CLEC12A/C19orf38/LYST/CASP1/HVCN1/RHOA/LTA4H/HLA-DMB/RAB32/LY86/ATP6V0B/RAB31/BLVRB/MPEG1/CX3CR1/AP1S2/HCK/ANXA2/RNF130/PLEK/ZEB2/FGL2/MS4A6A/CYBB/IFI30/SAT1/FTH1/CTSS/TYROBP,Genes in the expression cluster 'Late Progenitors Shared': up-regulated in hematopoietic late progenitor cells from adult bone marrow and fetal liver.,C2/CGP
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,126,-0.582201352141808,-1.92485550443579,7.24193047555269e-07,3.00540114735437e-05,2.42133243323881e-05,443,tags=49%, list=19%, signal=42%,PDIA6/MX1/VMP1/ADGRE5/IFI16/WSB1/ACAP2/RNASET2/MYO1G/RHBDF2/LY6E/DAPP1/BACH1/NOTCH2/PARVG/MYD88/CTSD/QKI/TNFSF10/COMT/UNC93B1/PIK3AP1/NBPF14/CD300A/CTSC/C1orf162/LILRB3/OAS1/SNX2/TGFBI/DUSP1/CAST/JAML/IFITM2/MARCKS/PECAM1/LTA4H/HLA-DMB/CD36/LY86/CD37/FPR1/CALHM6/NEAT1/CD302/BLVRB/NCF1/CSF3R/LILRB2/MS4A7/ZEB2/LYN/FGL2/CD14/MS4A6A/SAT1/MNDA/CEBPD/IFITM3/LST1/AIF1/FCN1,Genes down-regulated in monocyte-derived dendritic cells (MDDC) after stimulation with galecin-1 (lectin, LGALS1) [GeneID=3956] compared to that with bacterial lipopolysaccharide (LPS).,C2/CGP
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,44,-0.73550079985157,-2.11302959428402,1.045355955815e-06,4.22699062133398e-05,3.40551859289799e-05,186,tags=41%, list=8%, signal=38%,JUNB/SYNGR2/PTPRE/CAPG/MEF2C/NCF2/SRGN/PLEK/HLA-DMA/LYN/TNFAIP2/IFI30/HLA-DQB1/LGALS1/HLA-DQA1/HLA-DPB1/HLA-DRB1/CD74,Gene up-regulated by CD40 [GeneID=958] signaling in Ramos cells (EBV negative Burkitt lymphoma).,C2/CGP
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,21,0.788518079130779,2.34213010027482,1.17868051492506e-06,4.64694793009204e-05,3.74386153030143e-05,256,tags=71%, list=11%, signal=64%,RPL3/RPS3/EEF1B2/RPL5/RPS5/EEF1G/NOP53/RPL11/RPL4/RPLP0/RPL6/RPL7A/GATA3/RACK1/RPL13A,Genes distinguishing asparaginase resistant and sensitive B-lineage ALL; here - genes up-regulated in the drug resistant samples.,C2/CGP
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,58,-0.689794080055111,-2.09742910866839,1.26050078429406e-06,4.84831643129692e-05,3.90609614028995e-05,168,tags=47%, list=7%, signal=44%,ALDH2/CLEC7A/TNFRSF1B/PECAM1/HLA-DMB/LSP1/CTSH/CX3CR1/NCF1/CAPG/NCF2/CFP/HCK/PLEK/HLA-DMA/CSTA/TNFAIP2/SAT1/HLA-DQB1/S100A4/HLA-DQA1/S100A6/CTSS/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA,Genes up-regulated in at least one of three multiple myeloma (MM) cell lines treated with the DNA hypomethylating agent decitabine (5-aza-2'-deoxycytidine) [PubChem=451668].,C2/CGP
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,83,0.526224611157459,2.06903784967042,1.59906146615168e-06,6.00409507647904e-05,4.83726112693001e-05,463,tags=29%, list=20%, signal=24%,TCF7/CD3E/LEF1/CD3D/LCK/TRAT1/ITM2A/CDC25B/LAT/RHOH/ZAP70/TRBC2/PSIP1/GATA3/PRKCA/ARHGDIB/ASF1A/EIF3H/HMGN1/PPP2R5C/GRAP2/SRP9/OGT/TMEM131L,Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.,C2/CGP
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,27,-0.794802419936097,-2.07990760990691,1.93129918127477e-06,7.0829274624891e-05,5.70643356621456e-05,259,tags=59%, list=11%, signal=53%,PSME2/CTSC/BST2/CCL5/CASP1/HLA-DMB/MPEG1/HLA-DMA/LYN/CD14/HLA-DQA1/AIF1/SERPINA1/CTSS/HLA-DRB1/CD74,Genes up-regulated in gastric mucosal tissue of mice on 2% cholesterol [PubChem=5997] diet and infected with H. pylori vs those infected with H. pylori while on 0% cholesterol diet.,C2/CGP
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,26,-0.803183037760519,-2.09125912666654,2.39383388576308e-06,8.57971826783721e-05,6.912338517024e-05,248,tags=62%, list=11%, signal=56%,CTSC/CCL5/LILRB1/TIMP1/TMEM176B/CD14/IFI30/HLA-DQB1/S100A4/HLA-DQA1/S100A6/AIF1/SERPINA1/HLA-DPA1/HLA-DRA/LYZ,Top 100 probe sets contrubuting to the positive side of the 1st principal component; predominantly associated with spindle cell and pleomorphic sarcoma samples.,C2/CGP
MODY_HIPPOCAMPUS_PRENATAL,MODY_HIPPOCAMPUS_PRENATAL,17,0.812722914703646,2.3031670725453,2.61348237081934e-06,9.15880377507132e-05,7.37888472883963e-05,266,tags=76%, list=12%, signal=68%,RPS27/RPL30/RPS18/RPL13/RPL34/EEF1G/RPL9/RPL19/RPL37/RPS8/RPL23A/RPL13A/RPL12,Genes highly expressed in prenatal hippocampus (cluster 1).,C2/CGP
BEIER_GLIOMA_STEM_CELL_DN,BEIER_GLIOMA_STEM_CELL_DN,12,-0.907759825467217,-2.01914469654696,2.91363501534208e-06,9.98870091129231e-05,8.04749991651692e-05,162,tags=83%, list=7%, signal=78%,TIMP2/HLA-DMB/HLA-DMA/HLA-DQB1/FTH1/HLA-DQA1/HLA-DPA1/HLA-DRB1/HLA-DRA/CD74,Genes down-regulated in cancer stem cells derived from glyoblastoma tumors: CD133+ [GeneID=8842]  vs. CD133- cells.,C2/CGP
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,74,-0.63756956584537,-1.9914103758982,3.00772166295314e-06,0.000100918660903768,8.130616007132e-05,498,tags=53%, list=22%, signal=43%,APOBEC3G/IMPDH1/POLE4/HCLS1/SOD2/TMEM154/MX1/IFI16/LMO4/CAT/DBI/SCPEP1/CSTB/TNFSF10/PLCG2/PRKCB/CTSC/OAS1/CXXC5/CASP1/IFITM2/IFNGR2/PLBD1/HLA-DMB/PGD/FCGRT/ANXA5/FOS/CPVL/HLA-DMA/CSTA/TNFAIP2/CEBPD/IFITM3/FTL/HLA-DRA/S100A9/CD74/S100A8,Genes Downregulated in PBSHMS (RT4 blebbishield-to-immune cell fusion),C2/CGP
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,48,-0.700961061689647,-2.05226026044108,3.21062352116823e-06,0.000105482360268381,8.49829515361854e-05,347,tags=60%, list=15%, signal=52%,DAPP1/PLAC8/HSH2D/ARRB2/TNFSF10/EVI2B/LCP1/CDA/OAS1/LILRA5/IFITM2/MARCKS/TNFSF13B/CD37/FPR1/CALHM6/CARD16/CSF3R/IGSF6/SRGN/PLEK/CSTA/S100A11/S100A12/SPI1/IFITM3/FCER1G/TYROBP/S100A8,Genes strongly up-regulated (log2(FC)>3.58, padj<0.05) in post mortem lung tissue from COVID-19 patients vs uninfected biopsy.,C2/CGP
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,103,-0.597063158802945,-1.93987703672554,3.63995022418956e-06,0.000115428269217308,9.29959756668495e-05,347,tags=37%, list=15%, signal=33%,DAPP1/PLAC8/NOTCH2/MYD88/MIS18BP1/CRIP1/CD300A/HERPUD1/RAB11FIP1/PRKCB/NUP214/AOAH/LMO2/CASP1/SLC7A7/CNPY3/IFITM2/DUSP6/PECAM1/ALOX5/LTA4H/LY86/FPR1/CX3CR1/MEF2C/APLP2/CFP/LILRB2/CD14/MS4A6A/CFD/TYMP/S100A12/VCAN/HLA-DQA1/AIF1/FCN1/S100A9,Genes down-regulated in peripheral blood monocytes by HGF [GeneID=3082].,C2/CGP
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,142,-0.547920002004076,-1.84325863957395,3.65974220727038e-06,0.000115428269217308,9.29959756668495e-05,377,tags=36%, list=16%, signal=32%,NADK/RHBDF2/CIAO2A/ARAP1/IRF1/PLAC8/SH3BP2/CTSD/CUX1/LYL1/PLCG2/PIK3AP1/RAB11FIP1/SEC11A/VASP/PRKCD/TAGLN2/ABI3/CXXC5/GNB2/LMO2/PGLS/ALDH2/SERPINB1/TIMP2/ATP6V0C/PGD/TBXAS1/MYO1F/PLEKHO1/PTPN6/RAB31/CAPG/FCGRT/APLP2/HCK/ITGB2/STXBP2/PLEK/SH3BGRL3/OAZ1/LYN/TNFAIP2/FGR/EFHD2/COTL1/SPI1/IFITM3/PSAP/FCN1/TYROBP,Genes with promoters occupied by PML-RARA fusion [GeneID=5371,5914] protein in acute promyelocytic leukemia(APL) cells NB4 and two APL primary blasts, based on  Chip-seq data.,C2/CGP
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,68,0.547974736511575,2.09736633222851,5.10520723177376e-06,0.000154538105988943,0.000124505219055939,728,tags=65%, list=32%, signal=46%,EVL/LEPROTL1/IL6ST/TMEM123/PRMT2/PPP1R2/HINT1/ADD3/NCK2/PRDX2/HNRNPA1/RPL31/ACTN1/KIF2A/ZC3HAV1/LCP2/PEBP1/NACA/NUCB2/UBQLN2/NMRK1/STAT5B/CD69/CCNG1/MDFIC/CALM1/ICAM2/TTC3/RAD21/GORASP2/ZFAND1/CPSF6/MALT1/ATIC/INPP4A/FAM162A/IMPDH2/PPP3CC/DDX18/TRIM28/CNOT2/C1QBP/NUCKS1/CACYBP,Genes down-regulated in T helper cells (defines as CD4+) isolated from patients with mucosis fungoides compared to those from normal control donors.,C2/CGP
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,34,-0.755519933185369,-2.06937043549222,5.18284708824201e-06,0.000154538105988943,0.000124505219055939,198,tags=44%, list=9%, signal=41%,LGALS9/LYST/SLC7A7/LRP1/CD302/CTSH/CFP/CD68/CYBB/HLA-DQA1/SERPINA1/PSAP/S100A9/LYZ/S100A8,Genes down-regulated at early fetal liver stage (embryonic days  E11.5 - E12.5) compared to the late fetal liver stage (embryonic days E14.5 - E16.5).,C2/CGP
MARTINEZ_RB1_AND_TP53_TARGETS_UP,MARTINEZ_RB1_AND_TP53_TARGETS_UP,133,-0.549325956853977,-1.83648686410986,5.19373469715535e-06,0.000154538105988943,0.000124505219055939,326,tags=27%, list=14%, signal=25%,NCOA4/MOB1A/ZNF106/QKI/BID/LCP1/GLRX/CTSB/TGFBI/DUSP1/LGALS9/ACTB/SERPINB1/PECAM1/CD36/TIMP1/RAB31/PILRA/NCF1/NCF2/FOS/SRGN/TSPO/S100A10/FGL2/MS4A6A/CFD/MNDA/LGALS1/FTH1/HLA-DQA1/PSAP/TYROBP/CD74/LYZ/S100A8,Genes up-regulated in mice with skin specific double knockout of both RB1 and TP53 [GeneID=5925;7157] by Cre-lox.,C2/CGP
MORI_IMMATURE_B_LYMPHOCYTE_UP,MORI_IMMATURE_B_LYMPHOCYTE_UP,29,-0.774861616368557,-2.05027859746293,7.66184379795528e-06,0.000221236451588381,0.000178241429140724,184,tags=48%, list=8%, signal=45%,LAT2/DUSP6/HLA-DMB/ATP6V0B/NEAT1/PTPN6/CAPG/HCK/HLA-DMA/LYN/IFI30/MS4A1/CTSS/CD74,Up-regulated genes in the B lymphocyte developmental signature based on expression profiling of lymphomas from the Emu-myc transgenic mice: the immature B stage.,C2/CGP
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,24,-0.806683396038694,-2.05608319816344,7.71591936421112e-06,0.000221236451588381,0.000178241429140724,213,tags=67%, list=9%, signal=61%,CCL5/TGFBI/VIM/HLA-DMB/TNFSF13B/LSP1/HLA-DMA/PYCARD/S100A4/IFITM3/HLA-DQA1/S100A6/AIF1/FCER1G/HLA-DRB1/CD74,Partial list of genes up-regulated in the kidney of GLIS2 [GeneID=84662] knockout mice compared to the wild type.,C2/CGP
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,154,-0.52910625622511,-1.79474229179184,8.21275709112675e-06,0.000231277105941194,0.00018633078588327,277,tags=29%, list=12%, signal=28%,LCP1/ACTN4/GRINA/VASP/GLRX/CTSC/CTSB/VAMP8/TGFBI/IQGAP1/NAGK/ATP6V0D1/CD63/PGLS/SNX10/TPI1/DUSP6/PLBD1/ATP6V0C/HLA-DMB/ALDOA/CTSH/MPEG1/PRELID1/GAPDH/NPC2/ITGB2/STXBP2/CD68/HLA-DMA/LGALS3/CLIC1/CD14/CTSZ/CYBA/COTL1/IFI30/SAT1/HLA-DQA1/CTSS/PSAP/HLA-DRB1/TYROBP/HLA-DRA/CD74,Genes up-regulated in the Kras2LA mouse lung cancer model with mutated KRAS [GeneID=3845].,C2/CGP
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,48,-0.686427169169394,-2.00970821057837,1.00262347887799e-05,0.00027739249582291,0.000223484125393487,570,tags=73%, list=25%, signal=56%,COX17/PRDX1/CTSA/P4HB/BNIP3L/PSMB8/VAMP5/AKR1A1/DYNLT1/MX1/NDUFB7/YWHAH/ATOX1/CALR/PSMB9/LY6E/TXN/LYL1/BLOC1S1/GSTO1/EMP3/PSME2/BST2/STX7/VAMP8/GNG5/RHOA/TIMP1/BLVRB/TALDO1/ANXA2/PLEK/CLIC1/TYMP/IFI30,Genes up-regulated in peripheral blood mononuclear cells (PBMC) from sickle cell disease patients compared to those from healthy subjects.,C2/CGP
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,80,0.49666576991671,1.94248736262525,1.10135557252017e-05,0.000299454782390398,0.000241258834125562,309,tags=46%, list=13%, signal=41%,RPS12/RPS25/RPS3/RPS18/RPSA/RPL13/RPS14/RPS29/NOP53/GAS5/RPL35A/RPL10A/RPS28/RPL24/RPL39/RPL22/HINT1/RPL18A/RPS16/EEF1D/RPL23A/PRDX2/RPL28/RPS2/RPS10/RPS13/RPS7/RPLP2/SNHG6/RPL7A/RPS19/RPL13A/RPL41/RPLP1/DDX24/NACA/CDC42SE2,The '3/3 signature': genes consistently up-regulated in all three pools of normal mammary stem cells (defined by their ability to retain the dye PKH26).,C2/CGP
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,49,-0.682868477826787,-1.99955175742728,1.2217628890856e-05,0.000326562724760678,0.000263098627498006,277,tags=47%, list=12%, signal=42%,LCP1/TCIRG1/AOAH/CAST/CASP1/TIMP2/TNFRSF1B/LY86/AHNAK/CAPG/AP1S2/ANXA5/CFP/CTSW/ANXA2/CD68/S100A10/CSTA/TNFAIP2/TYMP/IFI30/LGALS1/AIF1,Genes specifically expressed in FAB subtypes M2, M4, M5 and M7 of pediatric AML (acute myeloid leukemia).,C2/CGP
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,78,-0.618506643399672,-1.94691791217177,1.30386143496099e-05,0.000342698247155581,0.000276098377543494,420,tags=51%, list=18%, signal=43%,FERMT3/IFI16/CHCHD10/PSMB10/PSMB9/PRDX5/PLAC8/NCF4/IRF7/SKAP2/BID/LYL1/LCP1/PSME2/GRINA/GLRX/ATP6V1B2/CTSB/CCL5/TGFBI/IQGAP1/LMO2/LAT2/FPR1/PLEKHO1/PTPN6/CTSH/MPEG1/NCF1/NCF2/CFP/HCK/ITGB2/SRGN/CTSZ/GRN/SAT1/LST1/TYROBP/LYZ,Genes down-regulated in adult fibroblasts with inactivated RB1 [GeneID=5925] by Cre-lox: acute loss of function (LOF) of RB1.,C2/CGP
IRITANI_MAD1_TARGETS_DN,IRITANI_MAD1_TARGETS_DN,21,0.750393621038847,2.22888927141239,1.58198628283965e-05,0.000408982355416086,0.000329500853043565,266,tags=52%, list=12%, signal=47%,RPL5/RPSA/NPM1/RPL13/EEF1G/GAS5/RPL10A/RPL18/RPL22/EEF2/RPL12,Genes down-regulated by overexpression of MAD1 [GeneID=4084] in primary thymocytes from RAG2 [GeneID=5897] knockout mice.,C2/CGP
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,60,-0.66005405532323,-2.01380164699044,1.74281206110917e-05,0.000443292680704704,0.000357143320502338,258,tags=43%, list=11%, signal=39%,GLUL/POLR2L/TUBA1A/MT2A/PRKCB/SWAP70/DUSP1/FLNA/ATP6V0D1/ALDH2/TIMP1/MEF2C/APLP2/NRGN/FOS/CSTA/GRN/COTL1/SAT1/S100A4/HLA-DQA1/FTL/HLA-DPB1/PSAP/HLA-DPA1/HLA-DRB1,Genes up-regulated in multiple myeloma (MM) cell lines treated with both decitabine [PubChem=451668] TSA [PubChem=5562].,C2/CGP
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,27,-0.764346216348268,-2.0002071862264,1.86021959865424e-05,0.000465645445567895,0.000375152056069452,266,tags=44%, list=12%, signal=40%,IER2/GLRX/RNH1/DUSP1/JUNB/FOS/CD68/SAT1/MNDA/VCAN/LYZ/S100A8,Genes changed in NIH 3T3 cells (embryonic fibroblast) by expression of one or more of C/EBP proteins: CEBPA, CEBPB, CEBPG,  and CEBPD [GeneID=1050;1051;1054;1052].,C2/CGP
YAGI_AML_RELAPSE_PROGNOSIS,YAGI_AML_RELAPSE_PROGNOSIS,20,-0.819423347766021,-2.00735920812504,2.03994649204108e-05,0.000502655565304498,0.000404969640771971,138,tags=55%, list=6%, signal=52%,RAB32/PGD/ATP6V0B/APLP2/NPC2/CD68/TSPO/TKT/CD14/GABARAP/TYMP,Genes associated with clinical prognosis of pediatric AML (acute myeloid leukemia): good prognosis=no relapse > 3 years; poor prognosis=relapse < 1 year or no response to therapy.,C2/CGP
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,111,-0.561035880432091,-1.83196526323111,2.20424760102397e-05,0.000534784379509968,0.000430854551325656,318,tags=28%, list=14%, signal=25%,PSMB3/CSTB/REL/COMT/LCP1/CIITA/BTK/COX8A/PRKCD/NUP214/SWAP70/HLA-DMB/POU2F2/NCF1/CAPG/CSF3R/CD68/HLA-DMA/TNFAIP2/CFD/HLA-DQB1/S100A4/LGALS1/HLA-DQA1/LST1/AIF1/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA/CD74,Genes specifically expressed in samples from patients with pediatric AML (acute myeloid leukemia ) bearing t(8;21) translocation.,C2/CGP
NADLER_OBESITY_UP,NADLER_OBESITY_UP,32,-0.739487022445713,-2.00860120787225,2.34852515383135e-05,0.000557990636886273,0.000449550911939213,342,tags=59%, list=15%, signal=51%,TPM4/PFN1/CSTB/CTSD/CFL1/CTSB/DUSP1/FLNA/LRP1/TLN1/CAPG/CD68/LGALS3/CTSZ/GRN/IFI30/CTSS/PSAP/FCER1G,Genes up-regulated in adipose tissue from obese mouse strains compared to the lean ones.,C2/CGP
LIAN_LIPA_TARGETS_3M,LIAN_LIPA_TARGETS_3M,16,-0.846835805523525,-2.0059578643451,2.37066408822957e-05,0.000557990636886273,0.000449550911939213,230,tags=75%, list=10%, signal=68%,CTSB/SLC11A1/MPEG1/CFP/IGSF6/MS4A7/CD68/CSTA/TNFAIP2/MS4A6A/FCER1G/S100A9,Genes up-regulated at 3 months of age in lungs from LIPA [GeneID=3988] knockout mice, which display pulmonary pathology.,C2/CGP
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,100,-0.572175820010301,-1.85016778839949,2.62369277020717e-05,0.000608465220384811,0.000490216280749235,283,tags=35%, list=12%, signal=32%,EVI2B/ADA2/PRKCB/GLRX/CTSB/FGD2/ODF3B/SCIMP/CASP1/JAML/ALDH2/TIMP2/ASAH1/LTA4H/TNFSF13B/CD36/LY86/CD37/CTSH/CSF3R/ANXA5/NCF2/MS4A7/RNF130/CD68/HLA-DMA/FGL2/CSTA/TNFAIP2/IFI30/SAT1/NKG7/CTSS/PSAP/CD74,Genes up-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChem=176158], an inhibitor of GSK3B [GeneID=2932].,C2/CGP
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,25,-0.777172190633379,-1.99701494993669,2.66502252327191e-05,0.000609092828869537,0.000490721919998353,379,tags=72%, list=17%, signal=61%,PSMB10/PSMB9/IRF1/TNFSF10/LILRB3/CASP1/SERPINB1/TIMP2/TNFSF13B/CD36/ITGB2/LGALS3/CYBB/SAT1/CTSS/FCER1G/TYROBP/CD74,Selected genes up-regulated in prostate tumors developed by transgenic mice overexpressing VAV3 [GeneID=10451] in prostate epithelium.,C2/CGP
MARTENS_TRETINOIN_RESPONSE_UP,MARTENS_TRETINOIN_RESPONSE_UP,51,-0.668949385021648,-1.99139200065681,2.83503242049898e-05,0.000638692303875269,0.000514569042337183,196,tags=37%, list=9%, signal=35%,SCIMP/PRAM1/LILRA5/TNFRSF1B/PGD/CD79B/MPEG1/NCF1/ITGB2/TNFAIP2/CD14/FGR/NAPSB/CD79A/NKG7/S100A6/SERPINA1/S100A9/S100A8,Genes up-regulated in NB4 cells (acute promyelocytic leukemia, APL) in response to tretinoin [PubChem=444795]; based on Chip-seq data.,C2/CGP
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,18,-0.81426835260315,-1.95276512117191,2.98908422443882e-05,0.000663913496047891,0.000534888755952211,356,tags=83%, list=16%, signal=71%,GLUL/IFNGR1/TGFB1/CDA/CTSB/TGFBI/TIMP2/TNFRSF1B/CEBPB/IFNGR2/ALOX5/FPR1/NCF2/HCK/CD14,Genes up-regulated in circulating endothelial cells (CEC) from cancer patients compared to those from healthy donors.,C2/CGP
FEVR_CTNNB1_TARGETS_UP,FEVR_CTNNB1_TARGETS_UP,110,-0.545539588828888,-1.77989240823297,3.36442865112002e-05,0.000736903330946705,0.000593693769283899,364,tags=35%, list=16%, signal=31%,LY6E/CAP1/IRF1/ZYX/MT2A/IRF7/PLCG2/CIITA/CTSB/STX7/OAS1/CCL5/TGFBI/DUSP1/MTPN/CAPNS1/JUNB/LYST/SLC7A7/SERPINB1/PTPRE/CEBPB/DUSP6/HLA-DMB/TNFSF13B/CD36/PGD/HCK/ANXA2/FOS/PLEK/HLA-DMA/LGALS3/TYMP/COTL1/LGALS1/HLA-DQA1/S100A6/S100A8,Genes up-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].,C2/CGP
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,27,-0.756172366823693,-1.97881715091452,3.5039143343176e-05,0.000756941493865597,0.000609837721920886,118,tags=48%, list=5%, signal=46%,JUNB/TIMP1/CSF3R/PLEK/FGL2/TNFAIP2/CD14/MS4A6A/CYBB/VCAN/CEBPD/LST1/FCER1G,Genes up-regulated in lung tissue upon LPS aspiration with mechanical ventilation (MV) compared to control (PBS aspiration without MV).,C2/CGP
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,177,-0.491930208308611,-1.69222992457654,3.66139869131803e-05,0.000780273748136289,0.000628635593231987,237,tags=20%, list=10%, signal=19%,NUP214/VSIR/OGFRL1/NAGK/CAST/PRAM1/CLEC7A/SERPINB1/TIMP2/TNFRSF1B/PTPRE/CEBPB/DUSP6/GLIPR1/ALOX5/PGD/CD37/NEAT1/LSP1/BLVRB/NCF1/CAPG/AP1S2/HCK/PLEK/CSTA/TNFAIP2/CYBB/LGALS1/FTH1/CTSS/FCER1G/TYROBP/S100A9/S100A8,Genes up-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.,C2/CGP
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,71,0.503101768070052,1.93089036069799,4.1010567396067e-05,0.000862315530447968,0.000694733401362145,424,tags=38%, list=18%, signal=32%,IL7R/ETS1/TRAT1/INPP4B/RPL5/TESPA1/CD28/ARHGAP15/ADD3/NCK2/ITGA6/GPR183/MBNL1/IPCEF1/ZC3HAV1/PIK3R1/ANKRD12/DOCK10/ZBTB25/HIVEP2/GPRIN3/STAT5B/CD69/PPP2R5C/MDFIC/ARHGEF3/STAT4,Genes with promoters bound by FOXP3 [GeneID=50943] and which are up-regulated only in developing (located in the thymus) regulatory CD4+ [GeneID=920] T lymphocytes.,C2/CGP
LEE_EARLY_T_LYMPHOCYTE_DN,LEE_EARLY_T_LYMPHOCYTE_DN,38,0.609921540157328,2.06085856387295,4.16704675773406e-05,0.000864662202229817,0.000696624021687675,306,tags=55%, list=13%, signal=49%,CCR7/GIMAP7/CD27/PIK3IP1/IFITM1/LDLRAP1/TRABD2A/KLF2/DENND2D/GIMAP4/PRMT2/S1PR1/CYLD/GIMAP1/GPR183/CYTIP/TNFRSF25/ATM/ACTN1/FOXO1/STK17A,Genes down-regulated at early stages of progenitor T lymphocyte maturation compared to the late stages.,C2/CGP
ROSS_AML_WITH_CBFB_MYH11_FUSION,ROSS_AML_WITH_CBFB_MYH11_FUSION,23,-0.782023890787354,-1.97411959662632,4.66857367633093e-05,0.000944019561125364,0.000760559096404441,210,tags=57%, list=9%, signal=52%,TGFBI/SLC7A7/CLEC7A/DUSP6/PLBD1/CFP/LGALS2/TNFAIP2/CYBB/CEBPD/CTSS/S100A9/S100A8,Top 63 probe sets for pediatric acute myeloid leukemia (AML) subtype inv(16); has a CBFB-MYH11 fusion [GeneID=865;4629].,C2/CGP
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,38,-0.705475479731517,-1.96959129334388,4.66921533086737e-05,0.000944019561125364,0.000760559096404441,244,tags=45%, list=11%, signal=41%,BST2/SWAP70/LMO2/TNFRSF1B/PTPRE/DUSP6/PECAM1/CTSH/SRGN/HLA-DMA/HLA-DQB1/HLA-DQA1/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA/CD74,Genes down-regulated in freshly isolated CD31- [GeneID=5175] (stromal stem cells from adipose tissue) versus the CD31+ (non-stem) counterparts.,C2/CGP
LIAN_LIPA_TARGETS_6M,LIAN_LIPA_TARGETS_6M,17,-0.834507201367989,-1.98276938331257,4.73072081291175e-05,0.000944347686324282,0.00076082345385536,230,tags=71%, list=10%, signal=64%,CTSB/SLC11A1/MPEG1/CFP/IGSF6/MS4A7/CD68/CSTA/TNFAIP2/MS4A6A/FCER1G/S100A9,Genes up-regulated at 6 months of age in lungs from LIPA [GeneID=3988] knockout mice, which display pulmonary pathology.,C2/CGP
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,17,-0.830403456367089,-1.97301898219995,5.48426864161712e-05,0.00108108645597878,0.000870988454004193,154,tags=59%, list=7%, signal=55%,DUSP6/GLIPR1/ALOX5/HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DQA1/AIF1/HLA-DPB1/HLA-DPA1,Genes down-regulated in quiescent (G0) CD34+ [GeneID=8842] cells isolated from peripheral blood of CML (chronic myeloid leukemia) patients compared to the quiescent cells from normal donors.,C2/CGP
KAMIKUBO_MYELOID_CEBPA_NETWORK,KAMIKUBO_MYELOID_CEBPA_NETWORK,12,-0.871820112571809,-1.93920341841116,6.06315130390956e-05,0.00118044316126733,0.000951036208423501,168,tags=92%, list=7%, signal=85%,ANXA1/GLRX/ALDH2/SERPINB1/PGD/RAB31/CYBB/LGALS1/S100A9/LYZ/S100A8,Network of differentially expressed myeloid genes centered around CEBPA [GeneID=1050].,C2/CGP
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,12,-0.869160873939391,-1.93328843139492,7.28448621979218e-05,0.00140093106934296,0.00112867456576241,177,tags=50%, list=8%, signal=46%,ARPC2/RHOA/TSPO/CYBA/HLA-DPB1/CST3,Genes down-regulated during transition from L0 (non-tumor, not infected with HCV) to L1 (non-tumor, infected with HCV) in the development of hepatocellular carcinoma.,C2/CGP
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,51,0.562689002358318,2.03795189346772,7.66260078571482e-05,0.00144485840450953,0.00116406507642292,475,tags=49%, list=21%, signal=40%,CD3D/LEPROTL1/IFITM1/NPM1/RPL36/ITM2A/RHOH/HINT1/EEF1D/CD96/PRKCH/TNFRSF25/PTPRCAP/PLSCR3/HNRNPA1/STAT5B/KMT2A/CCNG1/TGFBR2/PDCD4/STAT4/GLS/N4BP2L2/SORL1/TTC3,The 'MLL signature 2': genes down-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to the AML cases with intact MLL and NPM1 [GeneID=4869].,C2/CGP
MARTINEZ_TP53_TARGETS_UP,MARTINEZ_TP53_TARGETS_UP,129,-0.522566628446262,-1.73274129808529,7.69613861628409e-05,0.00144485840450953,0.00116406507642292,210,tags=25%, list=9%, signal=24%,NCOA4/MOB1A/ZNF106/CUX1/BID/LCP1/GLRX/TGFBI/DUSP1/LGALS9/ACTB/SERPINB1/PECAM1/CD36/RAB31/PILRA/NCF1/NCF2/FOS/SRGN/FGL2/MS4A6A/CFD/MNDA/LGALS1/FTH1/HLA-DQA1/PSAP/TYROBP/CD74/LYZ/S100A8,Genes up-regulated in mice with skin specific knockout of TP53 [GeneID=7157].,C2/CGP
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,51,-0.648572799220542,-1.93073304667077,7.95109022418507e-05,0.00147516109218116,0.00118847874929924,189,tags=29%, list=8%, signal=28%,ATP6V0D1/JUNB/NEAT1/BLVRB/MEF2C/APLP2/NRGN/GRN/COTL1/SAT1/S100A4/FTL/HLA-DPB1/HLA-DPA1/HLA-DRB1,Genes up-regulated in at least one of three multiple myeloma (MM) cell lines by TSA [PubChem=5562].,C2/CGP
KIM_LRRC3B_TARGETS,KIM_LRRC3B_TARGETS,20,-0.795745871376238,-1.94935597892029,8.24057330160738e-05,0.00151109117402731,0.00121742619033539,35,tags=50%, list=2%, signal=50%,PSME2/CCL5/IFITM2/HLA-DQB1/FTH1/SERPINA1/HLA-DPB1/HLA-DRB1/CD74/LYZ,Immune response genes up-regulated in zenograft tumors formed by SNU-601 cells (gastric cancer) made to express LRRC3B [GeneID=116135].,C2/CGP
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,113,-0.550764674705717,-1.80315728113293,8.65056454715191e-05,0.00156803911389179,0.00126330688547034,433,tags=38%, list=19%, signal=32%,NDUFB7/PKM/LAPTM5/TMSB10/LMO4/YWHAH/ENO1/PTPN12/TUBA1A/PFN1/PSMB3/CSTB/ANXA1/PLCG2/LCP1/GRB2/EMP3/MSN/CTSC/BST2/RHOG/OAS1/IQGAP1/CASP1/IFITM2/DUSP6/RHOA/ALOX5/RAB31/GPX1/APLP2/ANXA5/ITGB2/SRGN/TSPO/CLIC1/S100A10/GRN/S100A11/IFI30/VCAN/SERPINA1/HLA-DRA,Genes up-regulated in pancreatic ductal adenocarcinoma (PDAC) identified in a meta analysis across four independent studies.,C2/CGP
DEMAGALHAES_AGING_UP,DEMAGALHAES_AGING_UP,17,-0.823195229987543,-1.95589240671933,9.00331886809272e-05,0.00161343566533889,0.00129988108538133,107,tags=47%, list=5%, signal=45%,MPEG1/ANXA5/NPC2/LGALS3/S100A4/S100A6/CTSS/LYZ,Genes consistently overexpressed with age, based on meta-analysis of microarray data.,C2/CGP
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,70,-0.596264590972714,-1.85326786203584,9.17646735460904e-05,0.0016259875301369,0.00130999362472065,282,tags=34%, list=12%, signal=31%,BLOC1S1/GSTO1/EMP3/RHOG/ATP6V0D1/LAT2/IFNGR2/GLIPR1/MYO1F/RAB31/GPX1/ANXA2/RNF130/SRGN/SH3BGRL3/TSPO/GABARAP/SAT1/MNDA/SPI1/LGALS1/TYROBP/LYZ/CST3,Genes up-regulated in G1ME cells (megakaryocyte/erythroid progenitor lacking GATA1 [GeneID=2623]) upon knockdown of GATA2 [GeneID=2624] by RNAi.,C2/CGP
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,57,-0.627251657803678,-1.90099536580323,0.000106622184900796,0.00186825761765062,0.00150518101959369,213,tags=37%, list=9%, signal=34%,CCL5/AOAH/LGALS9/TNFRSF1B/GLIPR1/LY86/RAB31/ARPC1B/ITGB2/CSTA/CD14/CFD/TYMP/IFI30/S100A4/LST1/AIF1/FCER1G/FCN1/TYROBP/S100A8,Genes up-regulated in kidney biopsies from patients with acute transplant rejection compared to the biopsies from patients with well functioning kidneys more than 1-year post transplant.,C2/CGP
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,34,0.615734870095729,2.00891431005945,0.000110858568580966,0.00192114244672729,0.00154778822761395,259,tags=44%, list=11%, signal=40%,TCF7/CD3D/ETS1/CD27/CD6/RGCC/DGKA/CD2/FYB1/SATB1/ARHGAP15/NCK2/BCL11B/STK4/ACTN1,Genes down-regulated in ITNK cells (T-lymphocyte progenitors (DN3 cells) reprogrammed to natural killer (NK) cells by ablation of BCL11B [GeneID=64919] gene), compared to the parental DN3 cells.,C2/CGP
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,25,-0.751267988709227,-1.93045173636294,0.000120415367777863,0.00206407646723575,0.0016629444955135,202,tags=56%, list=9%, signal=52%,ZNF385A/LAT2/SERPINB1/HLA-DMB/CD36/CTSH/MEF2C/CFP/HLA-DMA/IFI30/MS4A1/HLA-DQA1/HLA-DRB1/CD74,Genes up-regulated during differentiation from small pre-BII to immature B lymphocyte.,C2/CGP
LUI_THYROID_CANCER_CLUSTER_3,LUI_THYROID_CANCER_CLUSTER_3,24,0.6884834468987,2.06087175387579,0.000132914455418759,0.0022538289913482,0.00181582057374581,181,tags=42%, list=8%, signal=39%,RPS12/RPS5/RPL10A/RPL21/RPL18/HSPA8/RPL17/HINT1/RPL18A/RPS2,Cluster 3: genes with similar expression profiles across follicular thyrorid carcinoma (FTC) samples; genes in this cluster correlated well with the presence of PAX8-PPARG [GeneID=7849;5468] fusion protein.,C2/CGP
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,26,0.663139043052602,2.03417984511012,0.000148204793941375,0.00248637191537818,0.00200317117902844,265,tags=58%, list=12%, signal=52%,LDHB/RPS25/RPS18/RPSA/RPS14/RPL35A/RPL10A/RPL11/CDC25B/RPS8/RPL29/RPS10/RPL7A/RPS19/SNRPD2,Top marker genes in medulloblastoma associated with poor response to treatment (poor outcome).,C2/CGP
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,91,-0.566437723249427,-1.81547272507422,0.000165571925273015,0.00274849395953205,0.00221435250752941,146,tags=38%, list=6%, signal=38%,PLBD1/CD36/FPR1/CTSH/BLVRB/MPEG1/CX3CR1/NCF2/IGSF6/HCK/ITGB2/CPVL/LGALS3/LGALS2/FGL2/CSTA/CD14/MS4A6A/FGR/CYBB/COTL1/IFI30/S100A12/MNDA/VCAN/NKG7/CEBPD/SERPINA1/PSAP/FCER1G/FCN1/TYROBP/S100A9/LYZ/S100A8,Genes down-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.,C2/CGP
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,17,-0.812442958250258,-1.93034526324735,0.000169126001459434,0.00277824691980757,0.00223832328685895,316,tags=71%, list=14%, signal=61%,CSTB/CTSD/CFL1/IQGAP1/MPEG1/SYK/CD68/CTSZ/COTL1/SAT1/CTSS/LYZ,Down-regulated genes classifying non-tumor lung tissues by age after incution of lung cancer by urethane injection [PubChem=5641]: early (24-26 weeks) vs late (46 weeks).,C2/CGP
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,32,0.606155021947098,1.95253767174309,0.000188314060132518,0.00306155951370083,0.00246657700032501,424,tags=50%, list=18%, signal=41%,CD3D/IFITM1/NPM1/RPL36/RPS21/ITM2A/EEF1D/BIN1/PTPRCAP/RPL31/RPL13A/SRSF5/STAT5B/KMT2A/CCNG1/STAT4,The 'MLL signature 1': genes down-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to all AML cases with the intact gene.,C2/CGP
VALK_AML_CLUSTER_5,VALK_AML_CLUSTER_5,10,-0.877927821365116,-1.87336545810887,0.00019584062561052,0.00315143537334479,0.00253898641366163,227,tags=90%, list=10%, signal=81%,LILRB3/LILRB1/IFNGR2/PILRA/LILRB2/EFHD2/TYMP/VCAN/PSAP,Top 40 genes from cluster 5 of acute myeloid leukemia (AML) expression profile; 96% of the samples are FAB M4 or M5 subtype.,C2/CGP
NUTT_GBM_VS_AO_GLIOMA_DN,NUTT_GBM_VS_AO_GLIOMA_DN,17,0.732441572197751,2.07565860532467,0.000199571355804743,0.0031790305869099,0.00256121878209809,437,tags=71%, list=19%, signal=58%,RPL30/RPS6/RPL4/RPL24/RPL23A/RPLP2/EIF3E/RPL36AL/RPS20/EIF3F/UQCRB/CIRBP,Top 50 marker genes for anaplastic oligodendroglioma (AO), a class of high grade glioma.,C2/CGP
GOLUB_ALL_VS_AML_DN,GOLUB_ALL_VS_AML_DN,13,-0.849883356014892,-1.92131754150359,0.000212880056650981,0.00335711849338597,0.00270469714081826,88,tags=54%, list=4%, signal=52%,CFP/SRGN/LGALS3/LYN/CFD/LYZ/CST3,Down-regulated genes highly correlated with acute lymphoblastic leukemia (ALL) vs acute myeloid leukemia (AML).,C2/CGP
RASHI_RESPONSE_TO_IONIZING_RADIATION_6,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,34,-0.700581914099618,-1.91889510388682,0.00022511625441131,0.00351493399214492,0.00283184282516365,137,tags=35%, list=6%, signal=34%,UNC93B1/EMP3/CCL5/ALDOA/CD79B/PLEKHO1/CFP/MS4A1/TYROBP/S100A9/LYZ/S100A8,Cluster 6: late responding genes activated in ATM [GeneID=472] deficient but not in the wild type tissues.,C2/CGP
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,15,-0.822243402549744,-1.91714163803338,0.000233078904099825,0.00360358266436691,0.00290326354229607,331,tags=80%, list=14%, signal=69%,NOTCH2/CRIP1/EMP3/CEBPB/PLBD1/LRP1/TIMP1/CD302/TMEM176B/CFD/S100A4/VCAN,Genes up-regulated in freshly isolated CD31- [GeneID=5175] (stromal stem cells from adipose tissue) versus the CD31+ (non-stem) counterparts.,C2/CGP
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,29,-0.721000563738386,-1.9077626164004,0.000241810111003768,0.00370227713643633,0.00298277776169186,155,tags=48%, list=7%, signal=46%,GLUL/IFNGR1/NOTCH2/SWAP70/CEBPB/ASAH1/GLIPR1/LY86/AHNAK/CSTA/MNDA/MS4A1/LYZ/S100A8,Genes up-regulated in ALL (acute lymphoblastic leukemia) blasts after 1 week of treatment with glucocorticoids.,C2/CGP
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,79,-0.559561730903728,-1.76688835435225,0.000285789278972642,0.00433355473980632,0.00349137307408886,283,tags=43%, list=12%, signal=39%,EVI2B/GRB2/PRKCB/BTK/CTSC/CPPED1/LGALS9/LAT2/LILRB1/SLC7A7/CLEC7A/GLIPR1/HLA-DMB/CD79B/NCF2/LILRB2/ITGB2/SRGN/PLEK/LGALS2/COTL1/IFI30/MNDA/CD79A/VCAN/MS4A1/HLA-DQA1/LST1/AIF1/CTSS/FCER1G/HLA-DRB1/CD74/LYZ,Genes up-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH).,C2/CGP
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,36,-0.683509506166038,-1.89456788684207,0.000291709730086401,0.00438120232710718,0.00352976084425349,301,tags=44%, list=13%, signal=39%,REEP5/PLCG2/HERPUD1/IQGAP1/CAST/SYNGR2/ASAH1/CTSH/BLVRB/AHNAK/CPVL/TSPO/S100A10/ZEB2/LYN/CEBPD,Genes up-regulated in Wilm's tumor samples compared to fetal  kidney.,C2/CGP
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,21,-0.764979323746766,-1.90265150620021,0.000349629750380457,0.0051685858572115,0.00416412450666107,139,tags=43%, list=6%, signal=41%,HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DQA1/HLA-DRB5/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA,Inflammatory cytokines, chemokines and their cognate receptors up-regulated in THP-1 cells (monocyte) after treatment with PSMD4 [GeneID=5710].,C2/CGP
MARTINEZ_RB1_TARGETS_UP,MARTINEZ_RB1_TARGETS_UP,153,-0.487085412089362,-1.65114331891914,0.000350690353025765,0.0051685858572115,0.00416412450666107,348,tags=25%, list=15%, signal=23%,CAP1/MAN2B1/BACH1/NCOA4/MOB1A/ZNF106/CUX1/EIF4EBP1/QKI/BID/LCP1/GLRX/RHOG/CTSB/VAMP8/DUSP1/LGALS9/JUNB/ACTB/PTPRE/PECAM1/CD36/PGD/TIMP1/RAB31/CX3CR1/NCF1/APLP2/NCF2/TSPO/S100A10/FGL2/CFD/LGALS1/FTH1/HLA-DQA1/PSAP/CD74/LYZ,Genes up-regulated in mice with skin specific knockout of RB1 [GeneID=5925] by Cre-lox.,C2/CGP
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,34,-0.689095594168535,-1.88743405324614,0.000390898229872143,0.00570783804174416,0.00459857859118593,184,tags=44%, list=8%, signal=41%,LAT2/ALDH2/SERPINB1/HLA-DMB/LY86/CD79B/NEAT1/PTPN6/CTSH/CAPG/HLA-DMA/MS4A1/HLA-DQA1/CTSS/CD74,Down-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the  Large Pre-BII stage.,C2/CGP
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,59,-0.602373416331337,-1.83725467564481,0.000401480023150834,0.00580856877531068,0.00467973334565965,364,tags=37%, list=16%, signal=32%,LY6E/GLUL/DBI/SH3BGRL/MAN2B1/ATP6V1F/CRIP1/BLOC1S1/PSME2/GRINA/CTSB/VAMP8/TPI1/TIMP2/NEAT1/TMEM176B/NPC2/GABARAP/CTSZ/GRN/FTH1/CST3,Genes down-regulated by TGFB1 [GeneID=7040] in MEF cells (embryonic fibroblast) via TGFB1R [GeneID=7046].,C2/CGP
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,28,-0.715905185244544,-1.87794541222756,0.000420814666680406,0.00603295208504545,0.00486051007352392,251,tags=68%, list=11%, signal=61%,NOTCH2/ANXA1/MSN/CTSC/SERPINB1/TIMP2/VIM/RHOC/BLVRB/CAPG/ITGB2/ANXA2/LGALS3/TNFAIP2/CYBA/IFITM3/LGALS1/HLA-DQA1/LYZ,Genes up-regulated in pancreatic islets upon knockout of HNF1A [GeneID=6927].,C2/CGP
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,187,-0.472715709900586,-1.63877771368601,0.00042609970954119,0.00605368686438249,0.00487721526236336,234,tags=17%, list=10%, signal=16%,VSIR/C4orf48/OGFRL1/NAGK/CAST/CLEC7A/SERPINB1/PTPRE/CEBPB/DUSP6/GLIPR1/ALOX5/RAB32/PGD/CD37/NEAT1/BLVRB/AP1S2/HCK/PLEK/ZEB2/CSTA/CYBB/LGALS1/FTH1/CTSS/FCER1G/TYROBP/S100A9/LYZ/S100A8,Genes up-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.,C2/CGP
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,10,-0.867279894875164,-1.85064439015622,0.00043040089217519,0.00606019827643102,0.00488246124864148,314,tags=100%, list=14%, signal=87%,CTSC/CTSB/FPR1/CTSH/ITGB2/SRGN/CYBB/CTSS/LYZ,Granule constituents expressed during mouse promyelocytic cell line differentiation to neutrophils.,C2/CGP
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,27,-0.707395625607599,-1.85117396224637,0.000444011315315534,0.00619651189604068,0.00499228372227154,131,tags=52%, list=6%, signal=49%,LAPTM5/ATG16L2/CAT/PLAC8/LCP1/GCA/MYO1F/CD302/CSF3R/SRGN/NKG7/LST1/LYZ/S100A8,Genes up-regulated in Kasumi-1 cells (acute myeloid leukaemia (AML) with the t(8;21) translocation) after knockdown of the AML1 MTG8 fusion [GeneID=861;862] by RNAi.,C2/CGP
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,212,-0.450379179922499,-1.56928126475091,0.000467781812223893,0.00647098173576385,0.00521341317963286,410,tags=26%, list=18%, signal=23%,IFI16/MEGF9/UQCRC1/YWHAH/WSB1/CAT/SERP1/ACTR2/PTPN12/PSMB9/ARPC5/SDCBP/IFNGR1/LRRFIP1/SH3BGRL/TUBA1A/MTDH/QKI/TNFSF10/COMT/EVI2B/GSTO1/NBPF14/HERPUD1/GDI2/HSBP1/PSME2/PPIB/GLRX/MSN/DYNLL1/TUBA1B/ATP6V1B2/SWAP70/SNX2/VIM/MARCKS/RHOA/RAC1/CX3CR1/APLP2/ANXA5/SRGN/TSPO/ZEB2/FGL2/VCAN/LGALS1/HLA-DQA1/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA/CD74/LYZ,Genes up-regulated in kidney biopsies from patients with well functioning kidneys more than 1-year post transplant compared to the biopsies from normal living kidney donors.,C2/CGP
LUI_TARGETS_OF_PAX8_PPARG_FUSION,LUI_TARGETS_OF_PAX8_PPARG_FUSION,26,0.637062264813722,1.95418929520259,0.000473474608758217,0.00649277789575398,0.00523097348074296,181,tags=35%, list=8%, signal=32%,RPS12/RPS5/RPL21/RPL18/HSPA8/RPL17/HINT1/RPL18A/RPS2,Genes down-regulated in follicular thyroid carcinoma (FTC) samples that bear PAX8-PPARG [GeneID=7849;5468] fusion protein.,C2/CGP
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,76,-0.562961608582122,-1.76683408027631,0.000493510021726943,0.00670638311686159,0.00540306673033537,207,tags=33%, list=9%, signal=31%,DUSP1/LGALS9/ACTB/ALDH2/RAB32/LRP1/FCGRT/FOS/OAZ1/TNFAIP2/FGR/GRN/CYBA/IFITM3/HLA-DQA1/LST1/SERPINA1/FTL/PSAP/FCER1G/FCN1/S100A9/LYZ/CST3/S100A8,Genes up-regulated in mature plasma cells compared with plasmablastic B lymphocytes.,C2/CGP
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,19,-0.759920842770667,-1.83124476652351,0.00049755664215143,0.00670638311686159,0.00540306673033537,251,tags=63%, list=11%, signal=57%,LAPTM5/CAP1/MSN/TAGLN2/FLNA/CAPNS1/VIM/RHOC/AP1S2/ANXA2/CLIC1/CD74,Top 50 marker genes for glioblastoma multiforme (GBM), a class of high grade glioma.,C2/CGP
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,29,-0.703370611070367,-1.86111388085078,0.000511420258530268,0.0068348283703579,0.00550654997364882,254,tags=48%, list=11%, signal=43%,ZYX/VASP/LYST/RAB32/PGD/ATP6V0B/APLP2/NPC2/CD68/TSPO/TKT/CD14/GABARAP/TYMP,Genes differentially expressed in pediatric AML (acute myeloid leukemia) samples from patients with good survival (>3 years without relapse) compared to those with poor survival (relapsed within one year after treatment).,C2/CGP
TIEN_INTESTINE_PROBIOTICS_6HR_UP,TIEN_INTESTINE_PROBIOTICS_6HR_UP,39,0.557985102760862,1.90389239430318,0.00053477828737606,0.00708693579152981,0.00570966291784967,268,tags=51%, list=12%, signal=46%,RPS27/EEF1A1/RPL5/RPS6/TPT1/RPL13/RPS14/EEF1G/RPS3A/RPL4/RPS23/RPL39/HSPA8/MYC/RPLP0/RPL23A/RPS2/RPS7/RPS19/RPL41,Genes up-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 6h.,C2/CGP
BHATTACHARYA_EMBRYONIC_STEM_CELL,BHATTACHARYA_EMBRYONIC_STEM_CELL,23,0.662483630212583,1.97817525280459,0.000552153155657292,0.00725621272059625,0.00584604262173993,170,tags=35%, list=7%, signal=33%,LDHB/IFITM1/NPM1/RPL4/RPL24/RPLP0/PSIP1/RPL6,The 'stemnes' signature: genes up-regulated and common to 6 human embryonic stem cell lines tested.,C2/CGP
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,10,-0.861705134939757,-1.83874869389727,0.000592257654233439,0.00767128451889564,0.0061804494972513,243,tags=90%, list=11%, signal=81%,PRKCD/LMO2/CX3CR1/FCGRT/ITGB2/PLEK/FGL2/HLA-DQB1/VCAN,Genes silenced by DNA methylation in bladder cancer cell lines.,C2/CGP
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,84,0.446733564560319,1.75443170757725,0.000593466525875249,0.00767128451889564,0.0061804494972513,268,tags=37%, list=12%, signal=34%,RPL3/RPS27/EEF1A1/RPS3/RPS18/RPL5/RPS6/TPT1/RPL13/RPL34/RPS14/EEF1G/RPL10/BTG1/RPS3A/RPL4/RPS23/RPL39/HSPA8/RPLP0/RPL23A/EIF4B/RPS2/RPS7/EEF2/PABPC1/RPS19/RACK1/RPL13A/RPL12/RPL41,Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 24h.,C2/CGP
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,34,-0.681413254824502,-1.86639211217261,0.000600194498377873,0.00769517661741386,0.00619969841285488,198,tags=38%, list=9%, signal=35%,LGALS9/LMO2/ALDH2/GLIPR1/ALOX5/CD37/NEAT1/MPEG1/CX3CR1/SAT1/HLA-DQB1/HLA-DQA1/LYZ,Genes down-regulated in P493-6 cells (B lymphocyte, Burkitt's lymphoma model) by MYC [GeneID=4609] and up-regulated by RNAi knockdown of TFRC [GeneID=7037].,C2/CGP
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,15,-0.80624768121485,-1.87984603516638,0.00065310531893608,0.00830602490292096,0.00669183463459974,349,tags=67%, list=15%, signal=57%,LRRFIP1/CAP1/SERPINB6/MIS18BP1/CPPED1/DUSP6/CD36/CD302/LYN/EFHD2,The glioblastoma multiforme (GBM) plasticity signature: genes up-regulated in neural stem cells (NSC) with double knockout of TP53 and PTEN [GeneID=7157;5728] vs those with knockout of TP53 alone.,C2/CGP
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,81,0.443731335676304,1.73400524551482,0.000709234524167039,0.00894770275689136,0.00720880901616519,246,tags=36%, list=11%, signal=33%,IL7R/TCF7/CD3E/LEF1/LTB/LCK/CD27/CD6/CD5/ITK/ABLIM1/CD2/ITM2A/GIMAP4/SATB1/ZAP70/PIM2/GIMAP1/PDE7A/TRBC2/PSIP1/FYN/EIF3E/SIT1/SNHG6/PTPRCAP/GATA3/MBNL1/ATM,Myeloid leukemia model in mice with germ-line MLL-AF9 fusion knock-in [GeneID=4297;4300]: genes changed in comparison among the leukemic, preleukemic and wild-type animals.,C2/CGP
CROONQUIST_NRAS_SIGNALING_UP,CROONQUIST_NRAS_SIGNALING_UP,12,-0.826162175538011,-1.83764573891194,0.000733164128954293,0.00917618913778508,0.00739289142562934,249,tags=83%, list=11%, signal=75%,SDCBP/RNASE6/CCL5/NCF1C/DUSP6/LY86/CX3CR1/NCF2/CYBB/LGALS1,Genes up-regulated in ANBL-6 cell line (multiple myeloma, MM)  expressing a constantly active form of NRAS [GeneID=4893] off a plasmid vector compared to those grown in the presence of IL6 [GeneID=3569].,C2/CGP
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,11,-0.834788472867591,-1.82315667243962,0.000771355007095077,0.00957816414321997,0.00771674673488403,14,tags=45%, list=1%, signal=45%,GLUL/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA,Down-regulated genes in pediatric adrenocortical carcinoma (ACC) compared to the adenoma (ACA) tumors.,C2/CGP
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,41,0.537877410878861,1.86145862356594,0.000869839941359131,0.0107166999025262,0.00863401981266835,392,tags=34%, list=17%, signal=29%,SARAF/CD6/RGCC/BTG1/MGAT4A/LY9/GATA3/PHF1/FOXP1/TOB1/SRSF5/CNST/EPC1/CD69,Down-regulated genes in angioimmunoblastic lymphoma (AILT) compared to normal T lymphocytes.,C2/CGP
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,21,0.670355223670016,1.99115174247464,0.000937809796132398,0.011464543011634,0.00923652732706491,247,tags=67%, list=11%, signal=60%,RPS18/EEF1B2/TPT1/RPL34/RPS29/RPL35A/RPL10A/RPL21/RPS23/RPL24/RPL39/RPS10/RPL36A/BCL2,Top down-regulated marker genes for medulloblastoma classification: desmoplastic vs classic morphology.,C2/CGP
ANDERSEN_LIVER_CANCER_KRT19_UP,ANDERSEN_LIVER_CANCER_KRT19_UP,24,0.637276575354854,1.90759167772519,0.000987305369566667,0.0119767735985126,0.00964921118272848,93,tags=38%, list=4%, signal=36%,RPS12/RPL3/RPS25/RPS18/RPS14/RPL9/RPL35A/RPS3A/RPL10A,Genes over-expressed in KRT19-positive [GeneID=3880] hepatocellular carcinoma.,C2/CGP
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,20,-0.740589576591273,-1.81423840321964,0.0010400148084503,0.01245880614026,0.0100375656718579,388,tags=65%, list=17%, signal=54%,ATP5MC3/UQCRQ/POLR2L/SEC61B/MT2A/NME2/PRKCB/RHOA/TIMP1/IFI30/SAT1/GSTP1/PSAP,Genes up-regulated in H460 cells (non-small cell lung carcinoma, NSCLC) after treatment with sodium butyrate [PubChem=5222465].,C2/CGP
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,21,0.668389461294248,1.98531285132917,0.00104284236557662,0.01245880614026,0.0100375656718579,321,tags=48%, list=14%, signal=41%,LEF1/TESPA1/SATB1/BCL11B/SCML4/CLEC2D/BCL2/PTPRC/FOXP1/SYNE2,Genes with promoters bound by FOXP3 [GeneID=50943] and which are down-regulated only in mature (peripheral blood) regulatory CD4+ [GeneID=920] T lymphocytes.,C2/CGP
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,54,0.485130945408316,1.78570843344541,0.0010776091161262,0.0127773652340678,0.0102942160915261,540,tags=41%, list=24%, signal=32%,LTB/RPS27/RPL5/TRAF3IP3/NOP53/RPL35A/RPL17/EEF1D/EPB41/RPS7/SNHG6/ATP6V0E2/ITGB2-AS1/EIF3L/PDCD4/EML4/TOMM20/OGT/FBL/PNISR/SRSF7/FAM117A,Up-regulated genes that vary between HNSCC (head and neck squamous cell carcinoma) groups formed on the basis of their level of pathological differentiation: well vs poorly differentiated tumors.,C2/CGP
WU_CELL_MIGRATION,WU_CELL_MIGRATION,34,-0.667695432272936,-1.82881897190105,0.00114445485015389,0.0134206725038214,0.0108125032287237,356,tags=62%, list=16%, signal=53%,GLUL/PLAC8/CSTB/MT2A/EMP3/MSN/BST2/CDA/TGFBI/VIM/ASAH1/GLIPR1/RAB31/CTSH/CAPG/SRGN/LGALS3/TNFAIP2/S100A4/VCAN/S100A6,Genes associated with migration rate of 40 human bladder cancer cells.,C2/CGP
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,84,-0.535486145810236,-1.70424988294798,0.00114888445657317,0.0134206725038214,0.0108125032287237,689,tags=58%, list=30%, signal=42%,RBM3/ATP5PF/CHMP2A/NDUFA2/NEDD8/FIBP/PSMA6/NDUFA13/TIMM8B/MRPL23/MRPL52/SEC61G/GUK1/DNAJC15/MIEN1/SF3B5/UBL5/OGFR/UQCR10/LAMTOR5/ROMO1/GPX4/COX6A1/COX7B/ATP5MPL/NAA38/TXNDC17/DBNL/UQCR11/CAT/CIAO2A/DBI/COX5B/ANXA1/REEP5/EIF4EBP1/PSME2/PPIB/TAGLN2/ATP5F1E/ELOB/SNX10/IFNGR2/ANXA2/S100A10/TKT/CYBA/LGALS1/S100A6,Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 13.,C2/CGP
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,109,0.392534539856661,1.61225573043674,0.00117417117450005,0.013532014446629,0.0109022070133706,333,tags=30%, list=15%, signal=27%,RPS27/RPS4X/EEF1A1/RPL32/RPS18/RPS6/TPT1/RPL13/RPL34/RPS29/ITM2A/RPL19/RPL37/RPS16/RPLP0/RPL23A/NCK2/ARL4C/PRKCH/GPR183/HSPB1/RPLP2/BIN1/PABPC1/RPL31/RPL13A/ACTN1/RPLP1/NACA/FOXO1/CYTH1/RPL37A/ATP6V0E2,Genes specifically expressed in samples from patients with pediatric acute myeloid leukemia (AML) bearing inv(16) translocation.,C2/CGP
STEARMAN_TUMOR_FIELD_EFFECT_UP,STEARMAN_TUMOR_FIELD_EFFECT_UP,10,-0.849130353438128,-1.81191600818537,0.0011755776659405,0.013532014446629,0.0109022070133706,316,tags=90%, list=14%, signal=78%,CSTB/CTSD/IQGAP1/MPEG1/CD68/CTSZ/SAT1/CTSS/LYZ,Up-regulated genes in the 'Field Effect' signature of normal lung tissue adjacent to the tumor.,C2/CGP
SANA_RESPONSE_TO_IFNG_UP,SANA_RESPONSE_TO_IFNG_UP,26,-0.697725503069732,-1.81667784004876,0.00146223263428487,0.0167097164077337,0.0134623553743848,244,tags=46%, list=11%, signal=42%,TNFSF10/BST2/OAS1/LGALS9/CASP1/HLA-DMA/HLA-DQB1/HLA-DQA1/HLA-DRB5/HLA-DPA1/HLA-DRB1/CD74,Genes up-regulated in five primary endothelial cell types (lung, aortic, iliac, dermal, and colon) by IFNG [GeneID=3458].,C2/CGP
VANLOO_SP3_TARGETS_DN,VANLOO_SP3_TARGETS_DN,18,-0.748304340401218,-1.79457129984913,0.00148120527548455,0.01680475337726,0.0135389228891318,344,tags=67%, list=15%, signal=57%,SERPINB6/MYD88/GLRX/RNH1/CRTAP/CD302/CTSH/CFP/LGALS3/TSPO/LGALS2/IFI30,Genes down-regulated in E12.5 hearts from mice with SP3 [GeneID=6670] knockout compared to the wild type organ.,C2/CGP
KENNY_CTNNB1_TARGETS_UP,KENNY_CTNNB1_TARGETS_UP,14,-0.785043214583079,-1.81503865251721,0.00156373608823161,0.0175185241511325,0.0141139796752107,55,tags=29%, list=2%, signal=28%,CTSC/TNFAIP2/CD14/S100A8,Genes up-regulated in HC11 cells (mammary epithelium) by expression of constantly active CTNNB1 [GeneID=1499].,C2/CGP
WIERENGA_PML_INTERACTOME,WIERENGA_PML_INTERACTOME,19,0.663029449397022,1.94744995214906,0.00156633602112219,0.0175185241511325,0.0141139796752107,71,tags=32%, list=3%, signal=31%,RPL3/RPS27/EEF1A1/RPS3/RPS18/EEF1G,Proteins identified in complex with PML [GeneID=5371] in K562 cells (lymphoblast).,C2/CGP
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,29,-0.675529914339441,-1.78744758555358,0.00160399331970052,0.0178133624307586,0.0143515191762678,497,tags=69%, list=22%, signal=55%,PGAM1/SPG21/HEXB/MFSD1/TPP1/SCPEP1/BLOC1S1/COX8A/RNH1/CCL5/SNX10/LY86/CAPG/MEF2C/ANXA5/STXBP2/SRGN/PYCARD/NKG7/LGALS1,Top 100 probe sets for pediatric acute myeloid leukemia (AML) subtypes with chimeric MLL fusions [GeneID=4297].,C2/CGP
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,78,-0.540456686971539,-1.70123444242128,0.00170491337239429,0.0188017369808797,0.0151478133270513,236,tags=24%, list=10%, signal=23%,TAGLN2/CTSB/OAS1/CRTAP/CASP1/SERPINB1/IFITM2/IFNGR2/RAB32/TIMP1/ANXA2/PYCARD/LYN/SAT1/IFITM3/HLA-DRA/S100A9/CD74/S100A8,Genes down-regulated in blebbishields compared to control RT4 live cells,C2/CGP
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,50,-0.581800498468057,-1.7113952221634,0.0017750414562663,0.0193085679852805,0.0155561469533982,350,tags=42%, list=15%, signal=36%,IFNGR1/BACH1/PLAC8/MYD88/MT2A/EMP3/VASP/PRKCD/CDA/ALDH2/SERPINB1/IFNGR2/ALOX5/LRP1/TIMP1/RAB31/LSP1/SYK/EFHD2/GSTP1/LYZ,Genes under-expressed in stem cell-like cholangiocellular carcinoma,C2/CGP
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,64,-0.56397460676734,-1.73232785381183,0.00177535977036504,0.0193085679852805,0.0155561469533982,497,tags=48%, list=22%, signal=39%,PGAM1/OSTF1/ZBTB7A/DOCK8/PKM/IFI16/MYO1G/DOK2/PSMB9/ARPC5/CAP1/TPM4/MYD88/EHBP1L1/TXN/VASP/C1orf162/ATP6V1B2/TAGLN2/RHOG/RNH1/CASP1/RHOA/CAPG/STXBP2/TSPO/TYMP/S100A11/SPI1/S100A6/FCER1G,Genes down-regulated in metastatic vs non-metastatic HNSCC (head and neck squamous cell carcinoma) samples.,C2/CGP
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,13,-0.802491463254561,-1.81417945691697,0.00201407385961183,0.0217547566890949,0.0175269441135651,249,tags=54%, list=11%, signal=48%,RNASE6/NCF1C/SLC7A7/DUSP6/CX3CR1/CYBB/SPI1,Genes up-regulated in ANBL-6 cell line (multiple myeloma, MM) expressing an activated form of NRAS [GeneID=4893] off a plasmid vector compared to those co-cultured with bone marrow stromal cells.,C2/CGP
PARK_APL_PATHOGENESIS_DN,PARK_APL_PATHOGENESIS_DN,20,-0.721223186072432,-1.76679613489506,0.00203704574807781,0.0218532050661136,0.017606260063945,186,tags=75%, list=8%, signal=70%,GLUL/ZYX/CTSD/JUNB/LYST/ASAH1/PECAM1/RAB31/LSP1/SRGN/CYBB/IFI30/MNDA/SPI1/LYZ,Genes down-regulated in U937 cells (acute promyelocytic leukemia, APL) expressing RARA [GeneID=5914] fused with either PML or PLZF [GeneID=5371;7704].,C2/CGP
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,26,-0.689812568176531,-1.79607481864997,0.00210922392636813,0.0223679646634268,0.0180209814429504,333,tags=46%, list=15%, signal=40%,YWHAH/PFN1/MYD88/FKBP1A/ARPC2/CEBPB/ATP6V0C/CD68/GRN/CD79A/FTH1/FTL,Genes down-regulated in T98G cells (glioma, express MGMT [GeneID=4255]) by carmustine [PubChem=2578] at 48 h.,C2/CGP
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,15,-0.777885381447678,-1.81371653426018,0.00211339678811071,0.0223679646634268,0.0180209814429504,186,tags=60%, list=8%, signal=55%,TGFB1/JUNB/CASP1/VIM/HCK/FOS/LGALS3/CYBB/LGALS1,Retinoic acid-responsive genes up-regulated in hepatocellular carcinoma (HCC) samples of TRIM24 [GeneID=8805] knockout mice.,C2/CGP
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,18,0.670222540574415,1.94803934120131,0.00222126619582594,0.0233529119387834,0.0188145143744696,242,tags=39%, list=11%, signal=35%,TCF7/RGCC/RPL14/TC2N/PRDX2/SNHG6/HNRNPA1,Top genes up-regulated at day 5 of Cre-Lox induced APC [GeneID=324] knockout in the intestine.,C2/CGP
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,42,-0.599023732905965,-1.70228178252702,0.0022474458318424,0.0234716693828839,0.0189101925342194,344,tags=43%, list=15%, signal=37%,SERPINB6/PLAC8/SKAP2/EIF4EBP1/QKI/EMP3/DUSP1/LGALS9/SNX10/ALDH2/RHOA/ASAH1/ATP6V0B/CAPG/TALDO1/TSPO/CLIC1/IFI30,Genes down-regulated in reverted NIH3T3 cells (fibroblasts transformed by activated KRAS [GeneID=3845] which then reverted to normal cells upon stable over-expression of a dominant negative form of CDC25 [GeneID=5923]) vs normal fibroblasts.,C2/CGP
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,66,0.425821013464423,1.61802448075709,0.00238103570431063,0.0247032454322228,0.0199024244813222,363,tags=29%, list=16%, signal=25%,LDHB/C12orf57/RPL3/LEPROTL1/EEF1B2/RPL13/TMEM123/CDC25B/PPP1R2/CNN2/TRBC2/RPL7A/TRBC1/MBNL1/RPL13A/ATP8B2/TMEM106B/CMPK1/ASF1A,Genes down-regulated in primary endothelial cells (HUVEC) after knockdown of WTAP [GeneID=9589] by RNAi.,C2/CGP
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,14,-0.770634893061696,-1.78172626920708,0.00257802934744674,0.026572237130219,0.021408196920318,91,tags=43%, list=4%, signal=41%,ATP6V1B2/ANXA5/FTH1/HLA-DQA1/LST1/HLA-DPA1,Genes up-regulated in common hematopoietic progenitor cells isolated from bone marrow of patients with Diamond-Blackfan anemia (DBA) and mutated RPS19 [GeneID=6223].,C2/CGP
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,45,0.504624318663055,1.80268961161658,0.00262205982932979,0.0268505737068382,0.0216324416541426,146,tags=24%, list=6%, signal=23%,LDHB/AQP3/RPS4X/RPS15A/RPL5/RPSA/RPL11/RPS23/LAT/MYC/RPL18A,Genes positively correlated with amplifications of MYC [GeneID=4609] in SCLC (small cell lung cancer) cell lines.,C2/CGP
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,40,-0.612369545744895,-1.72234181085407,0.00272761173188775,0.0277512496850773,0.0223580805459322,26,tags=32%, list=1%, signal=33%,RAB5IF/ENO1/LY6E/ARAP1/PLAC8/COX5B/DYNLL1/ATP6V0D1/IFITM3/FTL/S100A9/LYZ/S100A8,Genes up-regulated during skin tumor progression: epidermis treated with the carcinogen DMBA [PubChem=6001] followed by 20 weekly applications of the tumor promoter TPA [PubChem=4792], compared to the untreated skin.,C2/CGP
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,16,-0.742652287225428,-1.75917124230801,0.00286779332590112,0.0288624672561601,0.0232533444436039,158,tags=44%, list=7%, signal=41%,TNFRSF1B/LSP1/NCF1/TNFAIP2/FGR/SPI1/PSAP,Genes up-regulated by tretinoin (ATRA) [PubChem=444795] in U937 cells (acute promyelocytic leukemia, APL) made sensitive to the drug by expression of the PML-RARA fusion [GeneID=5371;5914].,C2/CGP
EPPERT_HSC_R,EPPERT_HSC_R,25,0.588707085841327,1.78639587961926,0.00288449334681643,0.0288624672561601,0.0232533444436039,580,tags=72%, list=25%, signal=54%,INPP4B/RGCC/TPT1/CYLD/PRKCH/RPL31/MLLT3/FOXO1/EPC1/RSL1D1/KMT2A/SPTBN1/OGT/PNISR/SMARCA2/PCNX1/DDX5/ASXL1,Genes up-regulated in human hematopoietic stem cell (HSC) enriched populations compared to committed progenitors and mature cells.,C2/CGP
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,21,-0.715740892642811,-1.78018600655242,0.00289173736618472,0.0288624672561601,0.0232533444436039,259,tags=48%, list=11%, signal=43%,PSME2/CTSC/SLC7A7/DUSP6/CTSH/MPEG1/CYBB/SAT1/CTSS/LYZ,Genes up-regulated in MEF cells (embryonic fibroblast) with ELAVL1 [GeneID=1994] knocked out.,C2/CGP
MARSHALL_VIRAL_INFECTION_RESPONSE_DN,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,12,0.731242494860094,1.88792053208892,0.00295959742467049,0.0293539945830526,0.0236493485043183,377,tags=67%, list=16%, signal=56%,TCF7/CD7/KLF2/RASA3/PIM1/TXK/TOB1/STAT5B,Genes down-regulated in the influenza-specific CD8+ [GeneID=925] T lymphocytes from bronchoalveolar lavage (BAL) compared to those from spleen.,C2/CGP
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,30,-0.659330708936966,-1.76115262366447,0.00300079018844858,0.0295765382948963,0.0238286431411674,356,tags=40%, list=16%, signal=34%,GLUL/BACH1/ZYX/HERPUD1/GRINA/VAMP8/ANXA2/SRGN/CLIC1/CTSZ/PSAP/CST3,Genes up-regulated in embryonic stem cells from TCEB3 [GeneID=6924] knockout mice.,C2/CGP
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,107,-0.482802037423501,-1.57176656373491,0.00317630020020617,0.0310117628455698,0.0249849466038799,159,tags=22%, list=7%, signal=22%,IFITM2/PECAM1/GLIPR1/CD37/LSP1/LILRB2/ITGB2/SRGN/PLEK/FGL2/TYMP/COTL1/HLA-DQB1/NKG7/MS4A1/CEBPD/IFITM3/HLA-DQA1/CTSS/HLA-DPB1/FCER1G/HLA-DRB1/HLA-DRA/LYZ,Genes up-regulated in prostate cancer samples from African-American patients compared to those from the European-American patients.,C2/CGP
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,76,-0.523380429504978,-1.64261002118434,0.0031919136152202,0.0310117628455698,0.0249849466038799,374,tags=39%, list=16%, signal=34%,COPE/GLUL/MAN2B1/ZYX/IRF7/EHBP1L1/THEMIS2/ANXA1/EIF4EBP1/CRIP1/GRINA/PTPN18/RNH1/PAK1/PGLS/TNFRSF1B/DUSP6/ATP6V0C/TIMP1/CAPG/NCF2/LILRB2/STXBP2/TSPO/TKT/GRN/S100A11/CEBPD/FCER1G/TYROBP,Up-regulated genes in B-CLL (B-cell chronic leukemia) patients expressing high levels of ZAP70 and CD38 [GeneID=7535;952], which are associated with poor survival.,C2/CGP
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,21,0.633184365123859,1.88074338411464,0.00324286500440646,0.0310117628455698,0.0249849466038799,295,tags=48%, list=13%, signal=42%,ITK/DENND2D/BTG1/ITM2A/ZAP70/MYC/PDE3B/THEMIS/FOXP1/FAM107B,Genes down-regulated by FOXP3 [GeneID=50943] in both ex vivo and hybridoma cells.,C2/CGP
CHICAS_RB1_TARGETS_CONFLUENT,CHICAS_RB1_TARGETS_CONFLUENT,90,-0.49833876050641,-1.59783287508867,0.00326137580654687,0.0310117628455698,0.0249849466038799,430,tags=43%, list=19%, signal=37%,G6PD/PKM/CDC42EP3/RASSF2/IFI16/HACD4/PSMB9/LY6E/TUBA1A/CD99/NOTCH2/ZYX/ANXA1/EIF4EBP1/EMP3/ACTN4/TUBA1B/VSIR/MTSS1/CXXC5/PAK1/FLNA/ACTB/TIMP2/VIM/IFITM2/TLN1/GNAI2/CTSH/BLVRB/AHNAK/CAPG/ANXA2/TSPO/S100A10/COTL1/S100A4/IFITM3/S100A6,Genes up-regulated in confluent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.,C2/CGP
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,44,0.487167221368234,1.73188218427338,0.00327684813458485,0.0310117628455698,0.0249849466038799,491,tags=34%, list=21%, signal=27%,RPS25/RPS27/RPS5/RPL24/ADD3/EIF4B/RPS19/ATM/RPL31/EIF4A2/TPR/RPL27/TTC3/RRP1B/FBL,Genes from 'subtype S2' signature of hepatocellular carcinoma (HCC): proliferation, MYC and AKT1 [GeneID=4609;207] activation.,C2/CGP
CAIRO_HEPATOBLASTOMA_CLASSES_UP,CAIRO_HEPATOBLASTOMA_CLASSES_UP,170,0.313087677661004,1.37025989508948,0.00328327926750646,0.0310117628455698,0.0249849466038799,177,tags=14%, list=8%, signal=14%,RPS3/EEF1B2/RPL5/RPS6/NPM1/RPL14/RPS14/RPL36/RPS21/RPL10A/RPL11/RPL19/RPL4/RPL24/RPS8/RPL18/RPL22/RPL18A/RPS16/EEF1D/RPLP0/RPL6/EIF4B/RPL28,Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).,C2/CGP
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,17,-0.745271178560593,-1.77074670259628,0.00328406112568811,0.0310117628455698,0.0249849466038799,238,tags=53%, list=10%, signal=48%,ATP6V1B2/TIMP2/IFNGR2/MARCKS/RHOA/FCGRT/APLP2/S100A4/CST3,The v1LDG up-regulated set: most variable late differentiation genes (LDG) with similar expression patterns in tonsil plasma cells (TPC) and multiple myeloma (MM) samples.,C2/CGP
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,106,-0.479377982651539,-1.56026469504981,0.00338841800369889,0.0317536297923704,0.0255826393614732,297,tags=32%, list=13%, signal=29%,UBE2J1/CRIP1/EVI2B/LCP1/EMP3/IER2/MSN/RNASE6/LAT2/ARPC2/ALDH2/TIMP2/IFITM2/PECAM1/GLIPR1/MYO1F/CD302/AP1S2/SRGN/HLA-DMA/LGALS2/FGL2/CYBB/COTL1/IFI30/HLA-DQB1/IFITM3/LGALS1/AIF1/HLA-DRB5/HLA-DPB1/HLA-DRB1/HLA-DRA/LYZ,Genes specifically up-regulated in Cluster IIb of urothelial cell carcinom (UCC) tumors.,C2/CGP
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,132,-0.461681800977103,-1.54451742918343,0.0034028937443948,0.0317536297923704,0.0255826393614732,861,tags=55%, list=38%, signal=37%,NDUFB3/ACAA2/AK2/ATP5MC1/UQCRFS1/HPS1/NDUFA3/NDUFS8/ACAA1/MRPL33/MAP3K1/TIMM17B/TBCB/ETFA/NDUFB5/NDUFB1/MDH2/NDUFAB1/ATP5PB/ATP5PF/NDUFA2/ACADVL/COX7A2/FIBP/TIMM13/SLC25A3/NDUFA6/ATP5F1D/TIMM8B/ATP5ME/COX17/CYB5R3/ATP5F1C/YWHAE/NDUFS6/GNAS/BAX/BNIP3L/PRDX3/GPX4/COX6A1/COX7B/SOD2/CYC1/ATP5MPL/NDUFB7/G6PD/UQCRH/ATP5F1B/ATP5MC2/UQCRC1/UQCR11/CAT/ATP5MC3/NDUFA1/COX6B1/ATP5MF/COX5B/NDUFB2/COX5A/TNFSF10/BID/NME2/COX8A/PRKCD/SLC25A5/ATP5F1E/ALDH2/LGALS3/TSPO/CYBB/TYMP/CYBA,Mitochondrial genes,C2/CGP
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,44,-0.594246192083003,-1.70721743663008,0.00345033607186462,0.0320069410901794,0.025786722221304,551,tags=55%, list=24%, signal=42%,XAF1/TRIM38/SP110/STAT2/MX1/IFI16/PARP14/LAP3/IRF1/IRF7/THEMIS2/TNFSF10/PIK3AP1/BST2/OAS1/LMO2/CASP1/GLIPR1/TNFSF13B/NCF2/CD68/ZEB2/IFITM3/CTSS,Genes up-regulated in HPIV3 (A549 cells, MOI: 2, 24hpi),C2/CGP
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,25,-0.683155713474045,-1.75543102208853,0.00347859729309838,0.032080397258574,0.0258459029410265,232,tags=44%, list=10%, signal=40%,CTSD/RHOG/JUNB/VIM/MPEG1/FOS/CD68/S100A10/CTSZ/SAT1/CTSS,Upregulated in the neocortex of aged adult mice (30-month) vs young adult (5-month),C2/CGP
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,30,0.551771013673194,1.7487882765039,0.00352082486192701,0.0322810512049936,0.026007561862582,271,tags=47%, list=12%, signal=42%,CD3G/LCK/RPL3/RPL34/DENND2D/NOP53/RPL10A/RPS2/EEF2/RPL36A/RPL31/RPL26/RPL12/EIF2S3,Down-regulated genes in MDA-MB-435 cells (breast cancer) undergoing G2/M arrest after treatment with 2-methoxyestradiol (2ME2) [PubChem=1573].,C2/CGP
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,15,0.689207587725596,1.87972125974049,0.00354782023913522,0.0323405347810187,0.0260554854191433,430,tags=47%, list=19%, signal=38%,CD3E/MGAT4A/CISH/GATA3/RGS10/PDCD4/RHOF,Genes up-regulated in primary LEC cells (lymphatic endothelum) upon overexpression of MIR31 [GeneID=407035].,C2/CGP
ONKEN_UVEAL_MELANOMA_DN,ONKEN_UVEAL_MELANOMA_DN,156,0.338041712700463,1.46232888995908,0.00365384581003846,0.0330438164230502,0.0266220915279655,312,tags=24%, list=14%, signal=22%,RPL3/RPS27A/RPL32/RPL5/RPSA/NPM1/RPL14/RPL13/RPS5/RPS14/ABLIM1/BTG1/RPL35A/RPL10A/RPL11/ITM2A/GYPC/RPL24/SATB1/RPS8/RPL22/RPL18A/RPL29/ADD3/PRKCH/EIF4B/RPL28/FYN/SNRPN/MBNL1/MZT2B/RPL31/ST13/RPS9/EIF4A2/ITPKB/PIK3R1,Genes down-regulated in uveal melanoma: class 2 vs class 1 tumors.,C2/CGP
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,34,-0.6384511502148,-1.74871883153393,0.00367353477945572,0.0330438164230502,0.0266220915279655,337,tags=47%, list=15%, signal=41%,CHCHD10/PLAC8/SULT1A1/EIF4EBP1/QKI/CRIP1/LYL1/TGFBI/MARCKS/CD36/AHNAK/APLP2/CFP/NPC2/HLA-DQA1/S100A6,Down-regulated genes from the 324 genes identified by two analytical methods as changed in the mammary tumors induced by transgenic expression of ERBB2 [GeneID=2064].,C2/CGP
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,13,0.740269809973735,1.95550357993855,0.00369048729934546,0.0330438164230502,0.0266220915279655,282,tags=62%, list=12%, signal=54%,LEF1/CCR7/NOSIP/LCK/SPOCK2/TRAC/FCMR/PEBP1,Genes exclusively down-regulated in B lymphocytes from CLL (chronic lymphocytic leukemia) patients but with a similiar expression pattern in the normal cells and in the cells from WM (Waldenstroem's macroblobulinemia) patients.,C2/CGP
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,24,-0.674296552008846,-1.71865420556943,0.0037087859904121,0.0330438164230502,0.0266220915279655,314,tags=54%, list=14%, signal=47%,CTSD/IRF7/TRAPPC5/RHOG/GNB2/SLC11A1/CTSH/MPEG1/FOS/CD68/LGALS3/CTSZ/CTSS,Upregulated in the cerebellum of aged adult mice (30-month) vs young adult (5-month),C2/CGP
SMID_BREAST_CANCER_BASAL_UP,SMID_BREAST_CANCER_BASAL_UP,62,-0.547164667274219,-1.68155260758484,0.00378143745586527,0.0335018363365143,0.0269910999954428,321,tags=31%, list=14%, signal=27%,YBX1/THEMIS2/QKI/GDI2/MSN/TAGLN2/OGFRL1/CCL5/FLNA/YBX3/CLEC7A/S100A10/LYN/COTL1/GSTP1/S100A4/S100A6/S100A9/S100A8,Genes up-regulated in basal subtype of breast cancer samles.,C2/CGP
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,30,-0.652231799929862,-1.74219057312814,0.00387279584565727,0.0340286469671955,0.0274155304137803,198,tags=47%, list=9%, signal=43%,ENO1/DOK2/CTSD/LGALS9/JUNB/CASP1/SERPINB1/RHOC/NCF2/FOS/PYCARD/CYBA/IFITM3/S100A6,Selected genes up-regulated during progression through benign to malignant skin tumors formed by treatment with DMBA and TPA [PubChem=6001;4792] chemicals in the two stage skin carcinogenesis model.,C2/CGP
LEE_LIVER_CANCER_MYC_E2F1_UP,LEE_LIVER_CANCER_MYC_E2F1_UP,16,-0.732694038421002,-1.73558245759431,0.00390563417949422,0.0340286469671955,0.0274155304137803,364,tags=62%, list=16%, signal=53%,LY6E/CSTB/TAGLN2/CD63/TMEM176B/ANXA5/ANXA2/HLA-DQA1/CTSS/CD74,Genes up-regulated in hepatocellular carcinoma (HCC) from MYC and E2F1 [GeneID=4609;1869] double transgenic mice.,C2/CGP
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,16,-0.732184329405519,-1.73437507500436,0.00390563417949422,0.0340286469671955,0.0274155304137803,262,tags=44%, list=11%, signal=39%,CIITA/JUNB/LAT2/DUSP6/HLA-DMB/HLA-DPB1/HLA-DPA1,Top 100 probe sets for core-binding factor (CBF) acute myeloid leukemia (AML): contains CBFB MYH11 [GeneID=865;4629] or AML1 ETO [GeneID=861;862] fusions.,C2/CGP
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,12,-0.788969375064102,-1.75491719803608,0.00422684669499485,0.0366249298791587,0.0295072525208721,161,tags=58%, list=7%, signal=55%,RNASET2/IRF7/VIM/CD68/CTSZ/IFITM3/S100A8,Genes up-regulated during epithelial to mesenchymal transition (EMT) induced by TGFB1 [GeneID=7040] in the EpH4 cells (mammary epithelium cell line transformed by HRAS [GeneID=3265]).,C2/CGP
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,33,-0.615422973919949,-1.67705184442573,0.00429647983138221,0.0370248562518565,0.0298294573280318,158,tags=55%, list=7%, signal=52%,LAPTM5/ADGRE5/PARP14/IFNGR1/GSTO1/NME2/TNFRSF1B/DUSP6/PECAM1/TBXAS1/CTSH/ANXA5/SRGN/LGALS2/IFI30/IFITM3/HLA-DRB5/FCER1G,Up-regulated genes specific to esophageal adenocarcinoma (EAC) relative to normal tissue.,C2/CGP
ENK_UV_RESPONSE_KERATINOCYTE_UP,ENK_UV_RESPONSE_KERATINOCYTE_UP,207,-0.423372990424437,-1.47333579837145,0.00440430128245646,0.0377477343610535,0.0304118515327514,389,tags=28%, list=17%, signal=26%,PPP1CA/ENO1/COPE/LY6E/COX6B1/CLTA/POLR2L/CAP1/SERPINB6/CD99/PFN1/COX5B/ATP6V1F/YBX1/PSMB3/CTSD/TGFB1/COMT/EMP3/IER2/ACTN4/CFL1/NME2/TCIRG1/VASP/CDA/TAGLN2/RNH1/VAMP8/GNB2/DUSP1/ELOB/JUNB/CASP1/TNFRSF1B/PTPRE/CEBPB/ATP6V0C/AP2S1/ALDOA/ATP6V0B/RAC1/BLVRB/CAPG/TALDO1/ANXA2/STXBP2/FOS/OAZ1/GABARAP/GRN/CYBA/S100A11/IFI30/S100A12/GSTP1/LGALS1/HLA-DRB1,Genes up-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.,C2/CGP
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,22,0.614006564081756,1.83845902489058,0.00445708756378459,0.0379936599356124,0.0306099840084666,225,tags=45%, list=10%, signal=41%,IL7R/CCR7/LTB/PIK3IP1/KLF2/BTG1/CD40LG/EPB41/PIM1/CISH,Genes up-regulated in CD34+ [GeneID=947] cells by intermediate activity levels of STAT5A [GeneID=6776]; predominant long-term growth and self-renewal phenotype.,C2/CGP
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,40,-0.59823839793692,-1.68259674698838,0.00487962530420921,0.0411807635456386,0.0331777069049066,184,tags=42%, list=8%, signal=40%,CMTM6/IFNGR1/SH3BP2/NCF4/LCP1/LAT2/HLA-DMB/NEAT1/PTPN6/CTSH/MEF2C/HLA-DMA/MS4A1/HLA-DQA1/CTSS/HLA-DRB1/CD74,Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the  mature B,C2/CGP
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,99,-0.481042744861179,-1.55231673648706,0.00490645439779591,0.0411807635456386,0.0331777069049066,443,tags=33%, list=19%, signal=28%,PDIA6/ETV6/CDC42EP3/HEBP2/MFSD1/CAT/UQCRQ/DBI/IFNGR1/SCPEP1/UBE2J1/CRIP1/BID/PIK3AP1/HSBP1/PAK1/CAST/CD63/SERPINB1/PTPRE/CEBPB/DUSP6/IFNGR2/ASAH1/ATP6V0B/LYN/TNFAIP2/SAT1/FTH1/S100A6/CTSS/S100A9/LYZ,The 'group 3 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].,C2/CGP
CHEOK_RESPONSE_TO_HD_MTX_UP,CHEOK_RESPONSE_TO_HD_MTX_UP,13,-0.776763972601008,-1.75601773537989,0.00490931106314525,0.0411807635456386,0.0331777069049066,77,tags=46%, list=3%, signal=45%,ANXA2/S100A4/TYROBP/S100A9/LYZ/S100A8,Genes specifically up-regulated in pediatric acute lymphoblastic leukemia (ALL) patients by high-dose methotrexate (HDMTX) [PubChem=4112].,C2/CGP
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,36,-0.606799663169849,-1.68194172168385,0.00505930265359031,0.0422143930408038,0.0340104611689418,403,tags=53%, list=18%, signal=44%,LMO4/RNASET2/PRDX5/MTDH/IRF7/PIK3AP1/GLRX/BST2/TGFBI/AOAH/AGTRAP/TNFRSF1B/RAB32/FPR1/SYK/IGSF6/TSPO/FGL2/MS4A6A,Class T (tolerizeable) genes: induced during the first LPS stimulation and either not re-induced or induced to a much lesser degree in tolerant macrophages.,C2/CGP
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,16,-0.724588987447559,-1.71638346927208,0.00510735048963607,0.0423027015451358,0.034081607826305,262,tags=69%, list=11%, signal=61%,CIITA/TGFBI/HLA-DMB/MPEG1/MS4A7/CPVL/LGALS2/HLA-DQB1/HLA-DQA1/HLA-DRB5/HLA-DRA,Strongly downregulated genes from differential gene expression analysis of platelets from 10 combined ICU and Non-ICU COVID-19 patients and, for comparison, 5 healthy donors,C2/CGP
GNATENKO_PLATELET_SIGNATURE,GNATENKO_PLATELET_SIGNATURE,26,-0.665551094296954,-1.73290487320576,0.00512353582442672,0.0423027015451358,0.034081607826305,425,tags=62%, list=19%, signal=51%,PKM/YWHAH/CD99/NCOA4/CFL1/DYNLL1/TAGLN2/CCL5/FLNA/ACTB/TLN1/MYL6/GPX1/NRGN/OAZ1/FTH1,Top 50 most up-regulated genes in human platelet cells.,C2/CGP
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,29,-0.639594415367892,-1.69236249826301,0.00518388172748984,0.0425780285638098,0.0343034278787294,235,tags=45%, list=10%, signal=41%,SWAP70/STX7/HLA-DMB/CD79B/PTPN6/POU2F2/CTSH/CAPG/HLA-DMA/GSTP1/HLA-DQB1/CD79A/MS4A1,Genes down-regulated in AIDS-related primary effusion lymphoma (PEL) samples compared to other tumor subtypes and normal B lymphocytes.,C2/CGP
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,26,-0.66465340857938,-1.7305675561043,0.0052795812803618,0.043139376575806,0.0347556836945552,213,tags=46%, list=9%, signal=42%,CCL5/TGFBI/FPR1/CTSW/IGSF6/FGL2/CSTA/NKG7/IFITM3/S100A9/LYZ/S100A8,Top up-regulated genes from principal component 1 (PCA1) which captures variation between normal plasma cells and tumors arising from aberrant expression of BCL2L1 and MYC [GeneID=598;4609].,C2/CGP
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,24,-0.666090923910033,-1.69773961361526,0.00533957652218409,0.0434047019354861,0.0349694458072501,210,tags=42%, list=9%, signal=38%,TGFBI/NAGK/MEF2C/AP1S2/S100A10/ZEB2/GRN/S100A11/CEBPD/LGALS1,Genes up-regulated in the neural crest stem cells (NCS), defined as p75+/HNK1+ [GeneID=4804;27087].,C2/CGP
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,62,-0.532332566090156,-1.6359704274593,0.00548140279372686,0.0443290882343962,0.0357141871634457,227,tags=31%, list=10%, signal=28%,LILRB3/DUSP1/LGALS9/LMO2/JUNB/LILRA5/ALDH2/GLIPR1/ALOX5/CD37/NEAT1/MPEG1/CX3CR1/SAT1/HLA-DQB1/FTH1/HLA-DQA1/SERPINA1/LYZ,Genes up-regulated in P493-6 cells (B lymphocyte, Burkitt's lymphoma model) upon knockdown of TFRC [GeneID=7037] by RNAi.,C2/CGP
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,48,-0.563981324070627,-1.65121362980009,0.0055630545855633,0.0447598830685374,0.0360612614649565,56,tags=15%, list=2%, signal=15%,CSTA/S100A11/IFITM3/FTL/S100A9/LYZ/S100A8,Genes up-regulated in squamous cell carcinoma (SCC) compared to normal skin.,C2/CGP
ZHAN_MULTIPLE_MYELOMA_DN,ZHAN_MULTIPLE_MYELOMA_DN,13,-0.772413296029325,-1.74618223130109,0.00559832980637956,0.0448150563688354,0.0361057124034204,111,tags=69%, list=5%, signal=66%,CTSH/SYK/ITGB2/S100A12/CEBPD/LST1/AIF1/S100A9/LYZ,Genes most significantly down-regulated in multiple myeloma samples, compared to normal bone marrow plasma cells.,C2/CGP
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,17,-0.727140337914443,-1.72766825382079,0.00571310928757582,0.0455028956894297,0.0366598772466987,331,tags=65%, list=14%, signal=56%,NOTCH2/ZYX/NME2/RHOG/PAK1/RHOA/RHOC/LRP1/TIMP1/ITGB2/VCAN,ECM related genes up-regulated early (within 30 min) in dermal fibroblasts after addition of TGFB1 [GeneID=7040].,C2/CGP
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,15,-0.746035927935399,-1.73945639025944,0.00585896677319823,0.0464301035242895,0.0374068918024346,212,tags=47%, list=9%, signal=43%,CXXC5/PLBD1/SERF2/CSTA/S100A12/S100A9/S100A8,Genes down-regulated on treatment of normal human bronchial epithelial cells with beta interferon (hIFNB treatment 100u/ml, 4-12hrs).,C2/CGP
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,25,-0.665666172024287,-1.71049004740667,0.00604534458307927,0.0475614973867749,0.038318410937381,410,tags=64%, list=18%, signal=53%,IFI16/TPP1/CD99/ANXA1/CIITA/TGFBI/PTPRE/HLA-DMB/RAB31/FCGRT/NCF2/IGSF6/ITGB2/HLA-DMA/FGL2/LST1,Genes down-regulated during the course of maturation of monocyte-derived dendritic cells (DC) in response to inflammatory stimuli (cluster D).,C2/CGP
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,65,-0.521311884161777,-1.60231783281091,0.00606205515202394,0.0475614973867749,0.038318410937381,313,tags=40%, list=14%, signal=36%,TPM4/NCF4/EVI2B/UNC93B1/PLCG2/LCP1/TCIRG1/CTSC/CDA/CLEC12A/CXXC5/TGFBI/GCA/CASP1/SERPINB1/HVCN1/CEBPB/RAB31/CX3CR1/ANXA5/NCF2/IGSF6/S100A11/NKG7/SPI1/HLA-DQA1,Genes up-regulated in immature bone marrow progenitor cells upon knock out of CBFA2T3 [GeneID=863].,C2/CGP
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,18,-0.7065103351751,-1.69434159619096,0.00620305201576085,0.0484267971725488,0.0390155486348272,345,tags=44%, list=15%, signal=38%,TUBA1A/ANXA1/CRIP1/TGFBI/FOS/SRGN/CFD/S100A4,Genes up-regulated in HeLa cells (cervical carcinoma) by trabectedin [PubChem=3199].,C2/CGP
WILENSKY_RESPONSE_TO_DARAPLADIB,WILENSKY_RESPONSE_TO_DARAPLADIB,13,-0.768913797553813,-1.73827097176191,0.0062896123650974,0.0488081336294125,0.0393227762845516,309,tags=69%, list=13%, signal=60%,ARRB2/EVI2B/CCL5/NCF1/ITGB2/CD68/HLA-DMA/CYBB/CTSS,Atherosclerotic process genes whose coronary expression changed after darapladib [PubChem=9939609] treatment.,C2/CGP
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,54,-0.548353516913083,-1.65000846165191,0.00631379788230828,0.0488081336294125,0.0393227762845516,177,tags=26%, list=8%, signal=25%,ARPC2/TIMP2/IFNGR2/MARCKS/PLBD1/ALDOA/CAPG/ANXA5/LGALS3/CLIC1/TKT/S100A11/VCAN/S100A6,Genes up-regulated in the stem cell-type subclass of hepatocellular carcinomas. Sets created as part of a metaanalysis of nine public transcriptomic datasets merged into a metadataset including 1133 human hepatocellular carcinomas obtained after curative resection. For platform descriptions of each one of the 9 datasets, see Figure 1B in Dsert et al., Hepatology (2017), 66: 1502-1518.,C2/CGP
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,16,-0.718379523947061,-1.70167468858408,0.00642262344481351,0.0494072057193703,0.0398054248928879,309,tags=56%, list=13%, signal=49%,ARRB2/ANXA1/MTSS1/CD63/ACTB/TIMP1/LILRB2/CPVL/AIF1,Genes up-regulated in hairy cell leukemia (HCL) compared with normal and other neoplastic B cell populations.,C2/CGP
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,29,-0.631676405681898,-1.67141149817375,0.00647949570140712,0.0496027413646555,0.0399629602023423,534,tags=62%, list=23%, signal=48%,BAX/PRR13/CTSA/GNB1/TMSB10/VCL/CAP1/TUBA1A/SERPINB6/CD99/SCPEP1/EMP3/MSN/ASAH1/RAB31/CAPG/ANXA5/PSAP,Progressively down-regulated 8-96 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.,C2/CGP
